The QualityStocks Daily Stock List
- Vulcan Energy Resources (VULNF)
- Mojo Organics, Inc. (MOJO)
- Sino United Worldwide Consolidated Ltd. (SUIC)
- Crop Infrastructure Corp. (CRXPF)
- CBD Life Sciences, Inc. (CBDL)
- Creative Medical Technology Holdings, Inc. (CELZ)
- Metrospaces, Inc. (MSPC)
- Gilla, Inc. (GLLA)
- Elcora Advanced Materials Corp. (ECORF)
- eWellness Healthcare Corp. (EWLL)
- Nuveen Municipal Value Fund Inc. (NUV)
- ECGI Holdings Inc. (ECGI)
- Mogo Inc. (MOGO)
- Salem Media Group Inc. (SALM)
Vulcan Energy Resources (ASX: VUL) (OTC: VULNF)
We reported earlier on Vulcan Energy Resources (VULNF), and today we report again on the Company, here at the QualityStocks Daily Newsletter.
Vulcan Energy Resources (ASX: VUL) (OTC: VULNF) is a mineral exploration firm that works on developing solutions for zinc, copper, lithium and other mineral opportunities. Established in 2018, the company has various projects located in south-central Norway’s Trondelag region. The projects include the Storwatz Project, the Lokken Project, the Killingdal Project, the Grimsdal Project and the Tverrfjellet Project. Formerly known as Koppar Resources Limited, the company changed its name in September 2019 and is based in Perth, Australia.
Vulcan Energy Resources is working on becoming the first producer of zero carbon lithium in the world. Through its Zero Carbon Lithium project, the company has developed a lithium extraction method which uses renewable geothermal power. The firm released the project’s pre-feasibility study in early 2021, with data showing that the project will produce roughly 39400 tonnes of battery grade lithium annually.
The Zero Carbon Lithium project will include the construction of geothermal power plants in addition to a direct lithium extraction plant on each site to extract a solution of lithium chloride from brine at a 90% recovery rate. The project, located in southwest Germany’s Upper Rhine Valley Area, holds one of the largest deposits of lithium in Europe. The project will help to not only reduce Europe’s reliance on China for imports but also reduce the continent’s water and carbon footprint of production.
Vulcan Energy Resources generates $2.17 million USD in sales and has a total of 15 employees in all of its locations. The company is listed on the Australian Stock Exchange as ASX: VUL. Additionally, the company’s 100% green technology will help the continent, which is the fastest growing lithium market globally, to transition to the electric vehicle industry, in a way that is both sustainable and environmentally friendly.
The firm’s shares have risen by 39.1% and with Europe’s worldwide battery cell production projected to reach nearly 15% by the year 2024, passing both Asia and the U.S., the company will occupy a huge chunk of that market. Investing in the firm will ensure a sustainable future.
Vulcan Energy Resources (VULNF), closed Tuesday’s trading session at $6.90, off by 1.4286%, on 4,596 volume. The stock's 52-week low/high is $1.67999994/$10.00.
MOJO Organics, Inc. (MOJO)
QualityStocks, SmallCap Network, StockGuru, Wolf of Penny Stocks, Epic Stock Picks and TopPennyStockMovers reported earlier on MOJO Organics, Inc. (MOJO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
MOJO Organics, Inc. engages in product development, production, marketing, and the distribution of beverages. The Company’s beverages are Non-GMO (Non-Genetically Modified) Project Verified. Its products include coconut water, sparkling coconut water, as well as tropical juice. Incorporated in 2007, MOJO Organics is based in Jersey City, New Jersey.
MOJO beverages have zero added sugar, no preservatives and low sodium. Additionally, MOJO is vegan and gluten free. The Company’s tropical juice comes in three flavors. These are mangosteen juice, dragon fruit juice, and pomel juice.
MOJO coconut water comes in four flavors. These are regular coconut water, pineapple juice, passion fruit juice, and mango juice. The Company’s sparkling coconut water comes in the same four flavors. MOJO Pure Coconut Water has been ranked in the top five brands of coconut water on Amazon.
MOJO Organics recently reported Q1 Net Revenue increased to $440,090 from $408,497 the highest first quarter revenue in the company's history. Operating Margin was 46% compared to 51% for 2019, while the company continued focusing on adding productive efficient distributors and brokers.
MOJO Organics, Inc. (MOJO), closed Tuesday’s trading session at $0.2799, up 113.6641%, on 377,510 volume. The average volume for the last 3 months is 18,520 and the stock's 52-week low/high is $0.061/$0.998000025.
Sino United Worldwide Consolidated Ltd. (SUIC)
MarketBeat, QualityStocks and Innovative Marketing reported previously on Sino United Worldwide Consolidated Ltd. (SUIC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Sino United Worldwide Consolidated Ltd. is a FinTech (Financial Technology) company. It provides Venture Financing and Blockchain services to five sectors. These include “Logistics & Trade”, “Vehicle & Transportation”, “Finance & Coin”, and “Medical & Healthcare”, and a new addition, “FinTech.” The Company previously went by the name AJ Greentech Holdings Ltd. It changed its name to Sino United Worldwide Consolidated Ltd. in July of 2017. Established in 2009, the Company is based in Flushing, New York. Sino United’s Asian operating center is located in Hong Kong and Singapore.
The Company’s primary business is in Blockchain, in 4 Sectors. These are Blockchain in Logistics and Trade; Blockchain in Vehicle and Transportation; Blockchain in Finance And Coin; and Blockchain in Medical and Healthcare. The addition of the FinTech sector to Sino United’s Blockchain services includes a complete update in which the Company will build up its own internal capabilities through actively starting a Blockchain training program, developing a 3rd generation Smart Contract Blockchain under the Sino United brand, and using these capabilities to provide a comprehensive ICO consultancy.
In December of 2018, Sino United Worldwide Consolidated and USADAE (American Digital Asset Exchange) revealed the Joint Venture (JV) to launch the new FinTech trading platform, embarking on the first worldwide Blockchain conglomerate as a hub for innovative Blockchain technology and unique Blockchain projects. The partnership adjoins the sanctioned practices of regulated and inventive finance and exchanges and the present flourishing digital world enabled by Blockchain, Distributed Ledger and Artificial Intelligence (AI) technologies.
This Sino United-USADAE alliance offers clients security and storage services, and also trade execution for crypto, digital assets. The alliance will merge their strong trading platform technology and premium selection of digital tokens, adopting rigorous assessment utilizing the latest in proof-of-reputation algorithms and other advanced programs.
Recently, Sino United Worldwide Consolidated announced that it and iDrink Technology Co. Ltd., Taiwan signed a Share Exchange Agreement (SEA) to work together on the distribution of iDrink Smart IoT (Internet of Things) Vending Machines in the global market. Upon closing of this SEA, Sino United will acquire a 20 percent stake in iDrink in exchange for delivery, by Sino United to iDrink, of 1,000,000 Sino United Worldwide Consolidated restricted common shares.
Upon closing, Sino United’s plan is to assist iDrink in developing its marketing plans and to implement strategic marketing alternatives internationally. Sino United’s belief is that this interaction is a major milestone, which will provide new growth opportunities for Sino United and iDrink, combining the complementary strengths to become a laterally positioned provider of smart IoT vending solutions.
Sino United Worldwide Consolidated Ltd. (SUIC), closed Tuesday’s trading session at $1.40, up 133.3333%, on 41,354 volume. The average volume for the last 3 months is 1,000 and the stock's 52-week low/high is $0.219999998/$1.95000004.
CROP Infrastructure Corp. (CRXPF)
CFN Media Group reported beforehand on CROP Infrastructure Corp. (CRXPF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
CROP Infrastructure Corp. concentrates on cannabis branding and real estate assets. The Company’s portfolio of projects includes cultivation properties in California, two in Washington State, a 1,000-acre Nevada cannabis farm, 2115 acres of hemp CBD farms, and an increasing portfolio of common share equity in upcoming listings within the cannabis space. CROP Infrastructure lists on the OTC Markets. Incorporated in 2011, the Company is headquartered in Vancouver, British Columbia. It previously went by the name Fortify Resources, Inc. It changed its name to Crop Infrastructure Corp. in March of 2018.
CROP Infrastructure has developed a portfolio of assets including Canna Drink, a cannabis infused functional beverage line and 16 Cannabis brands. The Company works to take advantage of strategic capital investment in land expansion opportunities; assist with key big ticket investments, including greenhouses, foundations, roads, advanced hydroponics, electrical distribution networks, as well as specialized lighting systems.
Furthermore, CROP is working to develop relationships with approved agricultural plant input partners for uniformly safe fertilizers, nutrients, herbicides, and pesticides as an element of a bulk distribution service and unique GROWSAFE-CROPSAFE client certification program.
Recently, CROP Infrastructure announced that its Emerald Heights retail brand secured a provisional licence for a retail, delivery, and smoking lounge in Cathedral City, California, to vertically integrate its California brands. Moreover, CROP retained a local real estate broker to find suitable locations to set up its Emerald Heights flagship location. CROP’s subsidiary will be able to run delivery routes in the Bay Area, Coachella Valley, and is now seeking a Southern California distribution partner.
In addition, CROP announced that its 30 percent owned DVG, LLC partner acquired additional facilities for a tenanted outdoor cannabis farm in Grant County, Washington. In return for acquiring the turnkey infrastructure and branding assets for DVG company, CROP is issuing 2,000,000 shares at a deemed price of $0.30 per share and has paid $46,000 USD cash. A Tier 3 licensed Tenant operates the farm and it is completely planted for the 2019 season.
Also, CROP announced recently that its investment holding, World Farms Corp., signed a definitive agreement with Graphite Energy Corp. to go public through a reverse takeover (RTO) on the Canadian Securities Exchange (CSE). Mr. Michael Yorke, CROP Chief Executive Officer, stated: “The RTO is proceeding as planned and is now subject to final approval by the CSE. By divesting our Italian and Jamaican assets to World Farms, it has allowed CROP to focus and expand its operations in the USA, as well as gain a major investment.”
CROP Infrastructure also announced that Hempire increased its ownership of Flip Distro to 51 percent for $100,000 in capital expenditures (capex) and product marketing at the distribution company. Increasing the ownership in Flip Distro, in concert with the recently announced acquisition of the Cathedral City dispensary, lounge and California-wide delivery provisional licences, will enable the company to use Flip for a secondary fulfillment center for delivery logistics. CROP’s Humboldt Holdings has an option to acquire 100 percent of Hempire’s interest in Flip at any time it becomes legal and compliant to do so.
CROP Infrastructure Corp. (CRXPF), closed Tuesday’s trading session at $0.068, up 106.0606%, on 701,536 volume. The average volume for the last 3 months is 47,190 and the stock's 52-week low/high is $0.003809999/$0.165000006.
CBD Life Sciences, Inc. (CBDL)
QualityStocks, StockRockandRoll, PennyStockLocks and Penny Stock 101 reported earlier on CBD Life Sciences, Inc. (CBDL), and today we report on the Company, here at the QualityStocks Daily Newsletter.
CBD Life Sciences, Inc.’s principal focus is to identify, evaluate and acquire undervalued opportunities with the aim of increasing shareholder value. The acquisition of LBC Bioscience, Inc. is the first in the CBD space. The Company is actively searching for additional opportunities within this developing sector. CBD Life Sciences lists on the OTC Markets. The Company is headquartered in Scottsdale, Arizona.
CBD Life Sciences announced this past March, that its wholly-owned subsidiary, LBC Bioscience, finalized the formulization for and is launching an organic - GMO free – CBD (cannabidiol) based anti-aging product line. The product line includes anti-aging day serum, CBD based eye gel, nourishing face serum with retinol, blemish balancing serum, CBD vitamin C face serum, and CBD based face cream. In addition, LBC Bioscience is working with Dr. Farhan Taghizadeh of Arizona Facial Plastics P.C. to develop a case study showing the effectiveness of the product line.
LBC Bioscience has also entered into negotiations to distribute its line of products in Japan. The initial order is $250,000. Ms. Lisa Nelson, President & Chief Executive Officer of CBD Life Sciences’ said this past April, “We are very excited about this opportunity to enter the Japanese market. The Japanese have embraced the benefits of CBD and we want to be on the forefront providing quality products to this aggressive expanding market.”
Recently, CBD Life Sciences announced that its LBC Bioscience completed the development of a disposable CBD vape-pen. This product is now undergoing final market testing. The anticipation is that it will be available for purchase within the next three to four weeks. LBC Bioscience is positioning itself to be a leader in the specialized CBD + e-cigarette vaping market.
CBD Life Sciences also announced that LBC Bioscience is continuing to experience substantial revenue growth due to the expansion and market acceptance of its product lines. LBC is experiencing growth in retail sales. Moreover, it now being approached to provide ‘white label’ versions of its product lines. LBC Bioscience has developed and is retailing/wholesaling a complete line of cannabidiol based organic products. These include hemp drops, massage oils, pain relief creams, anxiety and sleep supplements, CDB edibles, anti-aging skin solutions and a full line of CBD infused supplements for pets.
CBD Life Sciences, Inc. (CBDL), closed Tuesday’s trading session at $0.00965, up 135.3659%, on 671,450,168 volume. The average volume for the last 3 months is 220,407,239 and the stock's 52-week low/high is $0.0003/$0.012.
Creative Medical Technology Holdings, Inc. (CELZ)
We reported previously on Creative Medical Technology Holdings, Inc. (CELZ), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Creative Medical Technology Holdings, Inc. (CMT) is a clinical stage stem cell company listed on the OTC Markets Group’s OTCQB. The Company’s focus is on Urology and Neurology using stem cell treatments. Since 2011, CMT and its affiliate company, Creative Medical Health, Inc., have concentrated on regenerative medical solutions for unmet Urological and Neurological needs. The Company has a patent portfolio that encompasses all treatments. CMT has its corporate office in Phoenix, Arizona.
The Company has formed CaverStem International LLC. This is a majority-owned subsidiary centered on commercializing stem cell therapy for erectile dysfunction to global physicians and their patients. CaverStem is offering the Caverstem™ technology to selected physicians in the United States that qualify according to CMT's criteria.
CMT has also established CerebroStem LLC. This majority-owned subsidiary focuses on developing stem cell therapies for brain injuries and neurodegenerative diseases. Its initial focus will be treating radiation induced brain damage.
Via its own research and collaborations with top academic institutions, CMT has acquired a pioneering stem cell (AmnioStem) and developed proprietary protocols. Moreover, the Company has built an extensive intellectual property (IP) portfolio, developed complete treatment offerings for erectile dysfunction (ED), and launched a 40-patient trial for ED at UCLA. CMT is also making advances for treating stroke using its newly acquired amniotic fluid-based stem cell.
AmnioStem is Amniotic fluid derived stem cell. The AmnioStem patent covers means to isolate, grow, and use amniotic fluid derived stem cells in a scalable and commercializable way. AmnioStem cells do not necessitate matching with the recipient, as one size fits all.
Recently, CMT announced an update of its activities. Regarding CaverStem domestic activities, the Company is continuing marketing to physicians throughout the U.S. Additional physicians are scheduled for training, patients are being treated and revenues are being generated and growing each month. CMT anticipates reaching financial self-sufficiency by revenues from sales this year.
Creative Medical Technology Holdings, Inc. (CELZ), closed Tuesday’s trading session at $0.08055, up 159.9226%, on 240,831,537 volume. The average volume for the last 3 months is 116,500,926 and the stock's 52-week low/high is $0.0013/$0.083999998.
Metrospaces, Inc. (MSPC)
Investor News Source, PennyStocks24, AskSlapper, TradeThesePicks, QualityStocks, Pumps and Dumps, TryBestPennyStocks.biz, ResearchOTC, Orbit Stocks, Penny Stocks VIP, Daily Stock Motion, Penny Pick Insider, PennyPickAlerts, SmallCapAllStars, RisingPennyStocks, Super Hot Penny Stocks, Joe Penny Stocks, Super Nova Stock Picks, FOX Penny Stocks, Penny Stock Pick Report, WePickPennyStocks, Winning Penny Stock Picks, Penny Stock MoneyTrain, SixFigureStockPicks, Liquid Tycoon, Penny Stock Pick Alert, FatCat Stocks, Penny Stock Mobsters, Penny Stocks On Steroids, PennyDoctor, Simply Best Penny Stocks, Top Best Pennystocks, WINNINGOTC, WallstreetSurfers, DSR News, VIP Penny Stocks, MomentumOTC, OTCEquity, OTPicks, MarketWireStocks, Penny Dreamers, PennyStockInformer, MassiveStockProfits, eliteotc.com, OtcShortReport, Center Stage Stocks, Jet-Life Penny Stocks, Premier Equity Reports, The Stock Brainiac, Stock Edge, SmallCapVoice, Wall Street Beauties, PREPUMP STOCKS, Trading Wall St, Stock Commander, Your Stock Alert and PennyStockLaboratory reported previously on Metrospaces, Inc. (MSPC), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Metrospaces, Inc. is a real estate investment and development Company. It acquires land, designs builds, and develops, then resells condominiums and Luxury High-End Hotels, chiefly in urban areas of Latin America. The Company is operated by a premier group of real estate and investment professionals and entrepreneurs located in New York, New York; Miami, Florida; and Buenos Aires, Argentina. Metrospaces’ current projects are in Buenos Aires, Argentina, and Caracas, Venezuela.
A start-up real estate private equity firm, Metrospaces is based in New York City. The Company’s refocusing of its business plan to U.S.-based projects is now complete. Metrospaces has strong relationships with Investment Bankers, Real Estate Entrepreneurs, Political Leaders and High Net-Worth Individuals around the world. The Company’s focus is on mid-sized deals.
Metrospaces looks to use its international relationships in financing and real estate developers to find co-investment and development opportunities in home building, residential and hotel. Furthermore, it will invest in operating companies that are real estate based. This includes hotel operators and senior facilities operators. Metrospaces will also invest in corporate reorganization.
The Company focuses on joint ventures (JV’s) with established players. Metrospaces’ majority shareholders have partnered with Investors on elite properties including The London BLVGARI 5 Star Hotel and are presently involved in negotiations for the development of a number of elite luxury properties in South America.
Metrospaces has executed a JV Agreement with Prohotels of Argentina. The agreement calls for the development of four new hotels in the coming three years.
Recently, Metrospaces announced a management decision to focus capital resources to its Cannabis-related real estate Company, CannPartners. At present, Metrospaces is looking at two properties, one in Connecticut and one in California. The Company is also keeping a strong focus on the New York market. It is in advanced talks for acquisition of those properties.
Mr. Oscar Brito, Metrospaces Executive President, said, “The continuing legalization of medical and recreational cannabis growing and distribution will continue in the US for the foreseeable future. Many investors are focusing on the grow, distribution and ancillary industries such as paraphernalia etc. However, even with the billions of dollars currently being invested in the cannabis industry, there are very few institutional investors solely focusing on the cannabis-related real estate side of the business. In our opinion, this represents a once-in-a-generation opportunity to buy distressed and real estate located in out-of-favor locations across the U.S.”
Metrospaces, Inc. (MSPC), closed Tuesday’s trading session at $0.003, up 185.7143%, on 2,494,544,951 volume. The average volume for the last 3 months is 298,414,731 and the stock's 52-week low/high is $0.000000999/$0.003.
Gilla, Inc. (GLLA)
QualityStocks, MarketBeat, SmallCapFinancialWire, SmallCapVoice, TopPennyStockMovers, StockBlogs, Real Pennies, Marketbeat.com and Greenbackers reported previously on Gilla, Inc. (GLLA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Gilla, Inc. manufactures, markets, and distributes E-liquid (the liquid used in vaporizers and E-cigarettes) and other vaping hardware and accessories. The Company’s objective is to be a global leader in delivering the most efficient and effective vaping solutions for nicotine and cannabis related products. In addition, Gilla is a developer of cannabis concentrate products. The Company is based in in Toronto, Ontario. Gilla’s manufacturing facility is in Daytona Beach, Florida.
The Company’s proprietary product portfolio includes Spectrum Concentrates, Coil Glaze™, Craft Vapes™, Siren, The Drip Factory, Shake It, Surf Sauce, Ohana, Moshi, Crisp, Just Fruit, Cassidy's Outlaw Series, Vinto Vape, Vapor's Dozen, Enriched Vapor, and Crown E-liquid™.
Gilla previously announced its plan to pursue a spin-off of its cannabis-related business to the Company’s shareholders. The expectation is that the transaction will result in two separate public companies that will benefit from separating their respective corporate strategies and capital allocation priorities.
Gilla announced this past July that it entered into a Letter of Intent (LOI) to acquire all of the issued and outstanding shares of TB INVEST BVBA. TB Invest is a Belgium-based distributor and retailer of E-liquid and other vapor products.
The acquisition of TB INVEST would be a transformative acquisition for Gilla creating a vertically integrated business amalgamating Gilla's international manufacturing platform with TB Invest's European-centered distribution and retail business.
Gilla, Inc. (GLLA), closed Tuesday’s trading session at $0.05, up 1,900.00%, on 84,179 volume. The average volume for the last 3 months is 12,701 and the stock's 52-week low/high is $0.000027/$0.100000001.
Elcora Advanced Materials Corp. (ECORF)
QualityStocks and TopPennyStockMovers reported previously on Elcora Advanced Materials Corp. (ECORF), and today we choose to report on the Company once again, here at the QualityStocks Daily Newsletter.
Elcora Advanced Materials Corp. has been designed to become a vertically integrated (from mine to product) graphite & graphene company, which mines, processes, refines graphite, and produces the graphene and end user graphene applications. The Company has developed a unique low cost-effective process to make high quality graphite and graphene that are commercially scalable. Elcora Advanced Materials is based in Bedford, Nova Scotia. The Company lists on the OTC Markets’ OTCQB.
Elcora Advanced Materials is targeting high-end graphite applications (Li-ion batteries, graphene production & coating). It acquired the full operational control and a 40 percent equity interest in Sakura Graphite (PVT) Limited, operators of the Ragedara mine in Sri Lanka. Sri Lanka graphite is very high quality with many unique properties. This graphite is suitable for use in numerous high-end graphite applications.
Elcora has secured high-grade graphite and graphene precursor graphite from its interest in the operation of the Ragedara mine in Sri Lanka. This mine is already in production. Currently, the mine yields about 500 tonnes each year.
The Company developed its own unique graphite refining process. The process does not require the use of acids or alkaline systems. Environmentally friendly, the process yields higher quality graphite that has not been oxidized and will withstand high temperatures.
Elcora previously announced that it is building a state-of-the-art Lithium Ion (Li-ion) battery research and development laboratory in Halifax, Nova Scotia. The lab will concentrate on quality control and developing the Company’s graphite anode powder for Li-ion batteries.
Graphite powder will be routinely tested employing industry standard cells. This is to ensure the coulombic efficiency, reversible capacity, first-cycle loss and rate capabilities of the product are within Elcora’s specifications.
Recently, Elcora Advanced Materials announced that it is working with a number of battery manufacturers in Asia that are testing the Company’s graphite anode powder. Elcora has so far sent more than14 kgs of its EL-I-C6 graphite anode powder to battery manufacturers to test its electrochemical performance.
The purpose of this testing is to demonstrate that the Company’s EL-I-C6 graphite anode powder meets Li-ion battery manufacturing standards. After more testing, Elcora Advanced Materials hopes to enter into negotiations for long-term supply agreements.
Moreover, Elcora announced it signed a Memorandum of Understanding (MOU) agreement with Lockheed Martin Canada. This represents Lockheed Martin's first battery technology investment in Canada.
The strategic partnership supports the increasing energy demand for Lithium-Ion battery storage solutions applied to commercial, industrial, utility, and military applications. The MOU formally creates a working relationship and guidelines to support/identify opportunities within Lockheed Martin business units; including Lockheed’s energy division to help in maximizing and attaining sales goals.
Elcora Advanced Materials Corp. (ECORF), closed Tuesday’s trading session at $0.134, up 119.6721%, on 3,217,172 volume. The average volume for the last 3 months is 113,523 and the stock's 52-week low/high is $0.008/$0.14.
eWellness Healthcare Corp. (EWLL)
Penny Stock Hub, Dividend Investor, Proactive Investors, YCharts, Capital Network, OTC.Watch, Investing, The Street, OTC Markets, InvestorsHub, 4-Traders, Stockhouse, Stockwatch, Marketbeat, Investors Hangout, and Barchart reported beforehand on eWellness Healthcare Corp. (EWLL), and today we highlight the Company again, here at the QualityStocks Daily Newsletter.
Culver City, California-based eWellness Healthcare Corp. develops a telemedicine platform. This platform is for providing Distance Monitored Physical Therapy programs. These programs are for pre-diabetic, cardiac, and health challenged patients via contracted physician practices and healthcare systems. The Company has launched PHZIO. The design of this telemedicine platform is to extend and scale a physician’s practice. eWellness Healthcare is the first physical therapy telemedicine enterprise to provide insurance reimbursable real-time distance monitored treatments. eWellness Healthcare lists on the OTC Markets Group’s OTCQB.
The Company’s business model is to license its PHZIO platform to any physical therapy (PT) clinic in the United States and/or have large-scale employers use its PHZIO platform as a completely PT monitored corporate wellness program. eWellness Healthcare’s PHZIO is a Physical Therapy Telemedicine platform. It extends a traditional practice online.
The chief features of the PHZIO platform include video treatment protocols, real-time patient monitoring, patient induction forms, a patient video journal, and post treatment evaluations. In addition, main features include integrated billing, patient metrics, and user administration & customization.
Moreover, PHZIO scales a practice’s billable rates. It also provides tools to make growing a business easier. Pertaining to the Patient Dashboard, the PHZIO Dashboard enables clients to login securely to access prescribed treatment protocols. PHZIO is user-friendly and highly reliable to operate for PT and Patient. Furthermore, it’s a total on-line PT telemedicine intervention system.
eWellness Healthcare has launched a PHZIO PT clinic on-boarding website. The site includes a telehealth profitability calculator to illustrate to prospective PT clinics the additional profits they can make through using the PHZIO platform.
eWellness Healthcare anticipates adding Artificial Intelligence (AI) tools and predictive analytics into its PHZIO platform by the end of this year. The anticipation is that the new AI and predictive analytics will combine the Company’s existing remote monitoring capabilities with machine learning and intelligent analytics, which take advantage of patient health data to improve healthcare outcomes.
Evolution Physical Therapy has added eWellness Healthcare's Telehealth PT Services at its four clinical locations in Los Angeles, California. This includes Culver City, Playa Vista, Beverly Hills, and Brentwood. Mr. Darwin Fogt, Chief Executive Officer of eWellness Healthcare, owns Evolution Physical Therapy.
Recently, eWellness Healthcare and Total Release Physical Therapy announced an Integration & Marketing Agreement. Total Motion Release Seminars (TMR) is a proprietary physical therapy methodology developed by Mr. Tom Dalonzo-Baker, MPT. TMR is a full-body oriented assessment and treatment approach. TMR helps patients lessen their pain and impairments which limit their function. The treatment approach is created to allow physical therapists to interact and treat their patients remotely. The expectation is that integration with PHZIO will be extensively adopted within the TMR community.
eWellness Healthcare Corp. (EWLL), closed Tuesday’s trading session at $0.0032, up 113.3333%, on 1,125,290,237 volume. The average volume for the last 3 months is 569,200,568 and the stock's 52-week low/high is $0.000000999/$2.00.
Nuveen Municipal Value Fund Inc. (NUV)
MarketBeat, InvestorPlace, The Street, StreetAuthority Daily, Daily Wealth and Daily Trade Alert reported beforehand on Nuveen Municipal Value Fund Inc. (NUV), and today we highlight the Company again, here at the QualityStocks Daily Newsletter.
Nuveen Municipal Value Fund Inc. (NYSE:NUV) traded at a new 52-week high today of $11.77. Approximately 105,000 shares have changed hands today, as compared to an average 30-day volume of 298,000 shares.
Nuveen Municipal Value Fund Inc. (NYSE:NUV) is currently priced 0.2% above its average consensus analyst price target of $11.68.
Over the past year, Nuveen Municipal Value Fund Inc. has traded in a range of $8.30 to $11.77 and is now at $11.70, 41% above that low.
Nuveen Municipal Value Fund Inc is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax by investing in a portfolio of municipal obligations issued by state and local government authorities or certain U.S. territories.
Nuveen Municipal Value Fund Inc. (NUV), closed Tuesday’s trading session at $11.76, up 0.341297%, on 653,866 volume. The average volume for the last 3 months is 274,037 and the stock's 52-week low/high is $8.30000019/$11.9700002.
ECGI Holdings Inc. (ECGI)
We are reporting on ECGI Holdings Inc. (ECGI), here at the QualityStocks Daily Newsletter.
ECGI Holdings (OTC: ECGI), which plans to operate as Elite Cannabis Group and has been reorganized as an acquisition-oriented corporation with California-based targets of distressed cannabis assets, properties zoned for cannabis cultivation and processing, today announced its second agreement within the fast-growing California regulated cannabis market. According to the update, the company has signed a definitive management services agreement to enter the cannabis delivery business in conjunction with a California cannabis license holder operating out of Lynwood, California. ECGI created Nug Avenue Inc., a wholly owned subsidiary that will hold the contract with the licensed party.
“We are continuing to expand our investments within the California cannabis market,” said William Chung, CEO of ECGI. “Last month, we announced the acquisition of prime Northern California real estate that is zoned for cannabis cultivation with this new investment opportunity targeting the even faster-growing area of cannabis delivery. We plan on announcing our additional partnerships relating to this new agreement over the coming weeks, if not sooner. We are in the process of vetting additional similar transactions as part of our strategy to acquire distressed assets and other cannabis-related businesses with long term and hyper-growth potential.”
To view the full press release, visit: https://cnw.fm/nl8Rw
About ECGI Holdings Inc.
ECGI Holdings, which plans to operate as Elite Cannabis Group, is reorganizing as an acquisition-oriented corporation with California-based targets of distressed cannabis assets, properties zoned for cannabis cultivation and processing, and cannabis companies operating in market sectors with national expansion possibilities. Additional information about the company can be gained by contacting info@ecgiholdings.com.
ECGI Holdings Inc. (ECGI), closed Tuesday’s trading session at $1.50, up 20.9677%, on 31,921 volume. The average volume for the last 3 months is 6,632 and the stock's 52-week low/high is $0.100000001/$4.00.
Mogo Inc. (NASDAQ: MOGO) (TSX: MOGO)
QualityStocks, RedChip, InvestorPlace, MarketClub Analysis, The Online Investor, Red Chip, TopPennyStockMovers, StreetInsider, StockMarketWatch and Real Pennies reported previously on Mogo Inc. (MOGO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Mogo Inc. (NASDAQ: MOGO) (TSX: MOGO) offers a finance app that empowers consumers with simple solutions to help them get in control of their financial health and be more mindful of the impact they have on society and the planet. Users can sign up for a free account in only three minutes, begin to learn the four habits of financial health and get convenient access to products that can help them achieve their financial goals and have a positive impact on the planet, including a digital spending account with Mogo Visa Platinum Prepaid Card featuring automatic carbon offsetting, free monthly credit score monitoring, ID fraud protection and personal loans. Members can also easily buy and sell bitcoin 24/7 through the Mogo app, as well as participate in Mogo's new bitcoin rewards program. For more information, visit the company's website at www.mogo.ca
Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) a digital payments and financial technology company, recently announced that its wholly owned subsidiary, Carta Worldwide (“Carta”), has expanded into Japan in support of the TransferWise launch of their multi-currency debit card in the country.
Carta’s modern open-API issuer platform powers innovative solutions for industry leading banks and fintech companies across Europe, North America and Asia Pacific. With this most recent launch, Carta extends the reach of its modern issuer processing offering to support the rapidly growing fintech and payments sectors in Japan.
Carta’s launch into Japan will support the expansion of TransferWise’s recently launched multi-currency debit card program. Carta enables the issuance of virtual and physical card solutions to support innovative solutions for businesses and platforms that are looking to deploy payment products and embedded financial services.
“Our flexible platform offers unlimited opportunity for product innovation and is well positioned to meet the requirements of next-generation payments programs. We are extremely excited about the level of innovation in Japan and thrilled to be entering the market and offering Carta’s technology as a partner for card issuance in the Japanese market,” said Peter Kaju, CEO of Carta.
Mogo Inc. (MOGO), closed Tuesday’s trading session at $10.50, up 44.8276%, on 20,722,335 volume. The average volume for the last 3 months is 2,087,027 and the stock's 52-week low/high is $0.554799973/$11.8599996.
Salem Media Group Inc. (NASDAQ: SALM)
Greenbackers, Stock Analyzer, IRGnews Alert, StreetInsider, Wall Street Resources, Momentum Traders, SmallCap Network, The Street, The Momentum Traders Network, StockMarketWatch, BUYINS.NET, MarketBeat, PennyStocks24, SmarTrend Newsletters, PoliticsAndMyPortfolio, OTCReporter, QualityStocks, Penny Invest, TraderPower, OTCPicks, Stock Traders Chat, INO.com Market Report, MarketClub Analysis, SmallCapVoice, CRWEWallStreet, AllPennyStocks, MicrocapVoice, CRWEFinance, PennyToBuck, DrStockPick, Bull Warrior Stocks, PennyOmega, Wealth Insider Alert, Jason Bond, Wall Street Mover, BestOtc, Promotion Stock Secrets, CRWEPicks, StockHotTips, StockEgg, Marketbeat.com and TopPennyStockMovers reported previously on Salem Media Group Inc. (SALM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Salem Media Group Inc. (NASDAQ: SALM) is America's leading multimedia company specializing in Christian and conservative content, with media properties comprising radio, digital media and book and newsletter publishing. Each day, Salem serves a loyal and dedicated audience of listeners and readers numbering in the millions nationally. With its unique programming focus, Salem provides compelling content, fresh commentary and relevant information from some of the most respected figures across the Christian and conservative media landscape. For more information, visit the company's website at www.salemmedia.com
Salem Media Group , Inc. recently announced today that Regnery Publishing, a Salem Media Group company, has picked up Senator Josh Hawley’s The Tyranny of Big Tech after its cancelation last week by Simon & Schuster. Accusing Hawley of complicity in the storming of the U.S. Capitol on January 6, the New York–based publishing conglomerate made the Missouri Republican one of the highest-profile victims of the “cancel culture.” Regnery will publish the senator’s book in the summer of 2021.
Despite Senator Hawley’s immediate and forceful condemnation of the violent incursion, social media teemed with calls for retribution for his objection to the certification of the electoral vote. The next day, citing his purported “role in what became a dangerous threat to our democracy and freedom,” Simon & Schuster announced that it was dropping Hawley’s book, scheduled for publication in June. Responding to the impulsive decision, Hawley stated on Twitter, “Simon & Schuster is canceling my contract because I was representing my constituents, leading a debate on the Senate floor on voter integrity, which they have now decided to redefine as sedition.”
Salem Media Group Inc. (SALM), closed Tuesday’s trading session at $2.83, up 55.4945%, on 9,494,032 volume. The average volume for the last 3 months is 584,732 and the stock's 52-week low/high is $0.649999976/$2.61999988.
The QualityStocks Company Corner
- MustGrow Biologics Corp. (FRA: 0C0) (CSE: MGRO) (OTCQB: MGROF)
- Cybin Inc. (NEO: CYBN) (OTC: CLXPF)
- AzurRx BioPharma Inc. (NASDAQ: AZRX)
- Kaival Brands Innovations Group Inc. (OTCQB: KAVL)
- GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF)
- Net Element (NASDAQ: NETE)
- Predictive Oncology (NASDAQ: POAI)
- SRAX Inc. (NASDAQ: SRAX)
- Green Hygienics Holdings Inc. (OTCQB: GRYN)
- InsuraGuest Technologies Inc. (TSXV: ISGI) (OTCQB: ISGIF)
- HempFusion Wellness Inc. (TSX: CBD.U) (FWB: 8OO) (OTC: CBDHF)
- Excellon Resources Inc. (TSX: EXN) (FSE: E4X2) (NYSE American: EXN)
- Mohawk Group Holdings Inc. (NASDAQ: MWK)
- Siyata Mobile Inc. (TSXV: SIM) (NASDAQ: SYTA)
MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0)
The QualityStocks Daily Newsletter would like to spotlight MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0).
MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0), an agriculture biotech company focused on providing natural science-based biological solutions for high-value crops, as released additional lab results confirming its mustard-derived natural biopesticide ability to obtain 100% control of on the disease Fusarium wilt TR4. To view the full press release, visit: https://ibn.fm/hpV6D
MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) is an agricultural biotech company focused on developing and commercializing natural biological solutions for high-value crops, including fruits and vegetables. The company uses novel compounds from the mustard plant to provide superior and safer alternatives to current synthetic chemicals used as pesticides, fungicides and nematicides. Management & advisors own 22% of the company’s 37 million shares outstanding.
Leveraging its innovative platform, MustGrow effectively extracts the natural defense mechanisms of the mustard seed for broad use in crop production and protection. The company uses components of mustard seed to provide high quality, organic pest control to growers facing challenges associated with soil-borne diseases and pests like nematodes. This company’s all-natural, effective, safe and easy-to-use solution is ideal for farmers looking to raise healthy crops without chemical pesticides amid growing concerns worldwide over the negative effects of chemical pesticide solutions.
MustGrow, which went public in 2019, was founded in Saskatoon, Canada, and is currently focused on disrupting the $65 billion global pesticide market with its 100% owned and patented mustard-derived technology. Canada produces 28% of the global mustard crop and is the world’s largest exporter, with a 57% market share.
TerraMG and Pipeline
The company’s technology extracts the mustard plant’s natural organic compounds, which, when combined with water, form Allyl isothiocyanate (AITC) and serve as a natural defense mechanism for the plant against pests and diseases. MustGrow’s mustard-derived technology acts as both a natural bio-pesticide and as a non-selective bio-herbicide.
There are currently more than 110 independent third-party trials that confirm the safety and efficacy of MustGrow’s solutions, potentially positioning the company as a leading provider of safe plant protection solutions in a market that is gradually eliminating the use of chemical compounds.
MustGrow’s primary product at the moment is the new liquid formulation TerraMG, which has the potential to compete against existing chemistries on both efficacy and price. Its initial target market is as a pre-plant soil bio-pesticide for use with higher-value crops such as fruits and vegetables. This liquid formulation is safe and easy to transport and has already demonstrated its efficacy against several pests and diseases.
In addition to its use as a pre-plant soil treatment, TerraMG has significant potential for multiple applications in several other markets, which is expected to aggressively expand the company’s IP portfolio. MustGrow has already confirmed or is in the process of testing multiple applications of TerraMG, including fruit and vegetable soil fumigation ($1.2 billion estimated global market), container fumigation ($2 billion estimated global market), tobacco nematode and disease fumigation ($4 billion estimated global loss), non-selective herbicide ($13 billion estimated global market), food-borne pathogens ($15 billion estimated global market) and more.
The company anticipates registration approval for the liquid formulation (TerraMG) as a pre-plant bio-pesticide for soil-borne diseases and pests from the EPA (United States) and PMRA (Canada) in 2021. The company already has EPA and PMRA approval for the product’s granular form.
Currently, MustGrow’s pipeline also includes:
- TerraMG, a pre-plant soil bio-pesticide, for:
- Fruit & Vegetable – currently in Phase 4
- Turf & Ornamental – currently in Phase 4
- Tobacco – currently in Phase 4
- Potatoes – currently in Phase 4
- Canola – targeting Clubroot Disease – currently in Phase 3: Advanced Development/Field Trials
- Bananas – targeting Fusarium wilt TR4 – currently in Phase 1: Proof of Concept/Laboratory
- Pulse Crops – targeting Aphanomyces – currently in Phase 1: Proof of Concept/Laboratory
- Non-Selective Bio-Herbicide – targeting noxious or resistant weeds – currently in Phase 2: Early Development/Greenhouse
- Storage Bio-Pesticide for Bulk Grain, Fresh Produce – targeting toxins, diseases and insects – currently in Phase 1: Proof of Concept/Laboratory
- Storage Bio-Pesticide for Shipping Containers – targeting fungus, invasive pests and diseases – currently in Phase 1: Proof of Concept/Laboratory
- Bio-Pesticide for Foodborne Pathogens – targeting E. coli, salmonella, Listeria, human pathogens, etc. – currently in Phase 1: Proof of Concept/Laboratory
Market Opportunity
The protection of crops with synthetic chemical pesticides represents a $65 billion-dollar global market that is expected to grow in the coming years as the global population grows and needs more food. This number doesn’t include bio-pesticide sales, which are projected to increase to $8.5 billion by 2025, with a CAGR of 14.7%. MustGrow, with its natural bio-pesticide, is targeting not only the bio-pesticide market, but also the global synthetic chemical market so as to help replace harmful synthetic pesticides and provide a natural biologic that has the efficacy of controlling pests and disease compared to synthetic chemicals in some instances.
Management Team
Corey Giasson is the President, CEO and Director of MustGrow. He is an entrepreneur focused on the agriculture, mining, real estate and oil/gas industries, primarily in the Canadian province of Saskatchewan. Giasson is co-founder and director of Legacy Capital Corp. This private equity company focuses on participating in management buyouts of strong, sustainable cash flowing businesses. He has an MBA and B.Sc. in Agriculture Economics from the University of Saskatchewan.
Colin Bletsky is COO and Director of MustGrow. He grew up in Eastern Saskatchewan on his family’s third-generation farm, growing canola, wheat and oats. The majority of his time is spent helping other organizations and farmers grow their businesses – locally and globally. Bletsky has a Bachelor of Science in Agriculture from the University of Saskatchewan and executive education from the London School of Business and INSEAD.
Todd Lahti is the company’s CFO. He has extensive experience evaluating and managing biotech, agricultural and oil/gas start-up companies by working directly on financing transactions, mergers and acquisitions, business development, corporate strategy, technology transfer and operations setup. Lahti is a Chartered Financial Analyst and a Chartered Professional Accountant.
Brad Munro is Chairman of MustGrow. He is the President and CEO of Bittercreek Capital Corp., a private investment and advisory firm. He has extensive corporate finance and investment experience in the natural gas and oil industries, among others. Munro has a Bachelor of Commerce from the University of Saskatchewan.
MustGrow Biologics Corp. (OTCQB: MGROF), closed Tuesday’s trading session at $1.48, up 11.2782%, on 68,094 volume. The average volume for the last 3 months is 66,272 and the stock's 52-week low/high is $0.124499998/$1.87.
Recent News
- BioMedNewsBreaks - MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Releases Further Lab Results Validating Natural Biopesticide Control of Banana Disease
- BioMedNewsBreaks - MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Announces Trio of Upcoming Investment, Industry Events
- Half of All Covid-19 Medical Workers at Risk of Mental Health Issues, New Research Shows
Cybin Inc. (NEO: CYBN) (OTC: CLXPF)
The QualityStocks Daily Newsletter would like to spotlight Cybin Inc. (NEO: CYBN) (OTC: CLXPF).
Cybin Inc. (NEO: CYBN) (OTC: CLXPF) was featured today in a publication from PsychedelicNewsWire, examining how Health Canada granted five legal exemptions since August last year to Canadians who had requested access to magic mushroom therapy for both serious mental trauma and end-of-life care . In December, the body had announced that it would be revising its Special Access Program , which would make it easy for individuals (special cases) to access psychedelics.
Cybin Inc. (NEO: CYBN) (OTC: CLXPF) is a Canada-based life sciences company focused on the pharmaceutical development of psychedelic products, as well as the functional mushroom market.
The early-stage company boasts an experienced management team featuring industry veterans from pharmaceutical and consumer product backgrounds who have run multiple clinical trials and collectively helped facilitate billions of dollars in product revenues. The team is dedicated to the development of products and protocols within the psychedelic, pharmaceutical and nutraceutical industries.
In particular, Cybin aims to further build upon and expand its intellectual property (IP) portfolio, which is structured around unique psilocybin delivery mechanisms that target a number of different therapeutic indications. In addition, the company has dedicated itself toward furthering its research and IP within the fields of synthetic compounds, extraction methods, the isolation of chemical compounds, new drug formulations and protocol regimes.
Serenity Life Sciences & Natures Journey Inc.
The company’s business model is centered around its two core subsidiaries, Serenity Life Sciences and Natures Journey Inc., which comprise Cybin’s two-pronged approach toward delivering fungi-derived psychedelic and medicinal products.
Serenity Life Sciences is focused on furthering research and development of psilocybin-based medications. Psilocybin is found in certain species of mushrooms and is a non-habit forming, naturally occurring psychedelic compound. Research into psilocybin has shown positive results for the treatment of depression, anxiety, PTSD, addiction, eating disorders, ADHD and other indications.
Natures Journey Inc. operates the Journey brand, which specializes in developing proprietary medicinal mushroom products that target and promote mental wellness, immune boosting detoxification and overall general health and wellbeing.
Partnership with the Toronto Centre for Psychedelic Science (TCPS)
Staying true to its axiom of being a research-first medicinal mushroom life sciences company, Cybin recently announced its entry into a strategic partnership with the Toronto Centre for Psychedelic Science (TCPS), with the goal of furthering its ongoing psilocybin research efforts and expanding Cybin’s psilocybin IP portfolio (http://nnw.fm/9EUkI).
“While there is evidence to support psilocybin as a treatment for certain indications, the Toronto Centre for Psychedelic Science is taking a clinical approach to prove or disprove the safety and efficacy of psilocybin-based microdosing through an open science approach,” Paul Glavine, CEO of Cybin, stated in a news release.
“We are excited to join forces with Cybin and to offer our expertise. A number of firms had approached TCPS, but Cybin demonstrated a superior commitment to high-quality research and integrity in product development. Our high standards for scientific rigor and transparency will find a fitting home within the culture Cybin is cultivating in Canada and abroad,” Thomas Anderson, co-founder of the Toronto Centre for Psychedelic Science, added.
Journey’s Product Monetization & Market Potential for Nutraceutical Supplements
Although Cybin is at the forefront of companies seeking to conduct clinical trials aimed at gaining regulatory approval for psilocybin and other psychedelic products, the company has also placed a great deal of emphasis on generating meaningful revenue from its very outset.
Cybin’s Journey brand has is launching a range of supplements comprised of popular fungi-derived ingredients such as Reishi, Lion’s Mane and Cordyceps. Purported to aid focus and concentration while promoting neurogenesis, Journey’s range of nutraceutical products provides Cybin with a crucial foothold within the non-psychedelic legal supplement market, which is valued at over $25 billion globally and growing at a 9% year-over-year rate.
Pharmaceutical Psychedelics
In addition to the company’s range of non-psychedelic supplements, Cybin has plans to carry out a clinical trial with a new delivery system for its psilocybin-based medications later this year. Ultimately, the company aims to enter into technology transfer agreements with global pharmaceutical companies after phase 1 & phase 2 clinical trials are complete in order to accelerate regulatory approvals in major indications in global markets with entire lifecycle product management.
With products such as psilocybin truffles already legal in nations such as the Netherlands, Jamaica and Bulgaria, Cybin has positioned itself to capitalize on an eventual legalization of psychedelic mushroom-derived products in the future. Working within a regulatory environment with strong similarities to that which dealt with cannabis prior to the industry’s eventual legalization by the Canadian government in 2018, Cybin is laying the groundwork for the moment pharmaceutical psychedelics gain acceptance in North America and abroad.
Amalgamation Agreement and Financing
Cybin recently announced its entry into an amalgamation agreement dated June 26, 2020, with Clarmin Explorations Inc. (TSX.V: CX) and 2762898 Ontario Inc., a wholly owned subsidiary of Clarmin (http://nnw.fm/w04LH). Completion of the transactions contemplated in the amalgamation agreement will result in the reverse takeover of Clarmin by Cybin.
In connection with the proposed transaction, Cybin plans to complete a “best-efforts” brokered private placement of subscription receipts of Cybin, with a syndicate of agents co-led by Stifel Nicolaus Canada Inc. (Stifel GMP) and Eight Capital, to raise a minimum of C$14 million ($10 million) and a maximum of C$21 million ($15 million), with a 15% agents’ option.
To date, Cybin has raised approximately C$10,400,000 through an initial financing round and its series A financing round.
Cybin Inc. (NEO: CYBN) (OTC: CLXPF), closed Tuesday’s trading session at $1.65, off by 1.7857%, on 827,892 volume. The average volume for the last 3 months is 469,776 and the stock's 52-week low/high is $0.0284/$2.23499989.
Recent News
- Should Montreal Expect Psychedelic Revolution in the Near Future? Activists Think So
- Experts Predict What 2021 Psychedelics Space Might Look Like
- PsychedelicNewsBreaks - Cybin Inc. (NEO: CYBN) Positioned Amid Growing Acceptance, Legalization of Psilocybin
AzurRx BioPharma Inc. (NASDAQ: AZRX)
The QualityStocks Daily Newsletter would like to spotlight AzurRx BioPharma Inc. (NASDAQ: AZRX).
AzurRx BioPharma (NASDAQ: AZRX), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (“GI”) diseases, today announced its entry into an agreement with PPD Inc. (NASDAQ: PPD ), a leading global contract research organization (“CRO”), for its planned Phase 2 clinical trial evaluating a proprietary formulation of micronized niclosamide as a treatment for COVID-19-associated GI infections. To view the full press release, visit http://ibn.fm/cK75P
AzurRx BioPharma Inc. (AZRX) is a clinical-stage biopharmaceutical company focused on developing treatments for gastrointestinal diseases using recombinant proteins.
The company’s lead drug candidate is MS1819, a recombinant lipase for the treatment of exocrine pancreatic insufficiency (EPI) in patients suffering from cystic fibrosis and chronic pancreatitis.
AzurRx has already completed two Phase 2 clinical trials for MS1819 and is currently pursuing approval through parallel monotherapy and combination therapy pathways.
The company was founded in 2014 and is headquartered in New York City, with scientific operations in Langlade, France, and clinical operations in Hayward, California.
MS1819 Clinical Trials
The two current ongoing clinical trials for MS1819 in cystic fibrosis (CF) are the Phase 2b Option 2 monotherapy trial and the Phase 2 combination therapy trial, using MS1819 together with porcine pancreatic enzyme replacement therapy (PERT), the current standard of care. Pending the Phase 2b trial outcome, the company intends to initiate a Phase 3 trial in cystic fibrosis.
- Phase 2b CF Option 2 Trial – The study was initiated in Q3 2020, using MS1819 doses in enteric capsule form (2240mg and 4480mg). Topline data for the trial is anticipated in Q1 2021.
- Phase 2 CF Combination Trial – The study was initiated in Q4 2019, using daily dose levels of PERT in combination with MS1819 dosages (700mg, 1120mg and 2240mg). Topline data is anticipated in Q2 2021.
These trials are currently addressing the treatment of EPI in patients with cystic fibrosis and chronic pancreatitis – an established global market with an estimated value in excess of $2 billion that has been growing at a CAGR greater than 20% over the past five years.
Results from AzurRx’s Phase 2b Option 2 trial of MS1819 in cystic fibrosis patients demonstrate that the non-porcine MS1819 lipase is well-tolerated by patients, with no significant safety signals observed at the 2240mg daily dose level.
“[W]e have evaluated four different enteric capsules and identified the best suitable formulation for MS1819 that provides gastroprotection of enzyme content and delayed release into the duodenum,” James Sapirstein, President & CEO of AzurRx, stated in a September 2020 news release (https://ibn.fm/27t4W). “Our clinical program continues to advance, and we are determined to develop MS1819 as a safer alternative to porcine pancreatic enzyme replacement therapy, significantly reducing the pill burden of cystic fibrosis patients.”
Financial Highlights
As of July 2020, AzurRx had raised gross cash capital of $22.1 million, including $15.2 million from Series B convertible preferred stock and warrants in July 2020 and $6.9 million from convertible promissory notes and warrants in December 2019 and January 2020. Notably, AzurRx solidified its financial position and created an effectively debt-free balance sheet by exchanging substantially all of its outstanding convertible notes into the Series B convertible preferred stock financing.
The company secured an additional $2.5 million in French Research Tax Credits, received in 2020, for the years 2017-2019 (https://ibn.fm/Qxk7O).
In a letter to shareholder, Sapirstein noted that ensuring the company maintains sufficient capital to support its business operations has been a key focus. He further stated that the company is in “a financially secure position” to complete its two Phase 2 MS1819 clinical trial programs and to begin preparations in 2021 for a pivotal Phase 3 study.
The company has no current plans to access additional financing, as it believes it has enough cash to fund existing operational and clinical objectives through Q3 2021.
Management Team
James Sapirstein is the President and CEO of AzurRx BioPharma. He was previously the CEO and a board member for ContraVir Pharmaceuticals Inc., which is now known as Hepion Pharmaceuticals Inc. (NASDAQ: HEPA). Mr. Sapirstein has almost 36 years of experience in the pharmaceutical industry, with expertise in drug development and commercialization. He currently serves on the Emerging Companies and Health Section boards of the BIO (Biotechnology Innovation Organization) and is Chairman Emeritus of BioNJ. He earned his Bachelor’s degree in Pharmacy from Rutgers University and has an MBA in management from Fairleigh Dickinson University.
Daniel Schneiderman is the Chief Financial Officer of AzurRx. He previously served as the CFO of Biophytis SA and its U.S. subsidiary, Biophytis, Inc., clinical-stage biotechnology companies focused on the development of pharmaceutical candidates for age-related diseases. He was appointed to the AzurRx position in January 2020, bringing to the team over 18 years of experience in capital markets and finance operations. Mr. Schneiderman holds a degree in economics from Tulane University.
James Pennington, M.D., is the Chief Medical Officer of AzurRx. Before joining the team, he was the Chief Medical Officer and Senior Clinical Fellow for 11 years at Anthera Pharmaceuticals. Before becoming a part of the biotech industry, Dr. Pennington was on the Medical Faculty of Harvard Medical School for 10 years. He received his medical degree from Oregon Health & Science University.
Martin Krusin is the Senior Vice President for Corporate Development at AzurRx. He has 20 years of experience in business development, strategic marketing, financing and operations in the health care, financial services and consulting sectors. Before joining AzurRx, he was the VP for Business Development at FluoroPharma Medical Inc. Mr. Krusin received his MBA from Columbia Business School in finance and marketing, an MPhil. in political economy from Oxford University and a BA in international relations from Swarthmore College.
Dinesh Srinivasan, Ph.D., is the Vice President for Translational Research at AzurRx. He has over 15 years of experience leading drug discovery and development in the pharmaceutical industry. He began his career as a post-doctorate fellow at Roche Palo Alto. Dr. Srinivasan received his MSc in Biotechnology from the University of Mumbai, India, and a Ph.D. in Pharmacology and Toxicology from the University of Arizona – Tucson.
Ted Stover is the Product Development Director at AzurRx. He joined the company in 2020 to oversee CMC and Project Management. Before joining AzurRx, he spent 20 years focused on manufacturing operations and analytical method development for all stages of pharmaceutical drug development. Mr. Stover earned his MBA from the University of Florida.
AzurRx BioPharma Inc. (AZRX), closed Tuesday’s trading session at $1.82, up 7.6923%, on 8,688,102 volume. The average volume for the last 3 months is 7,190,532 and the stock's 52-week low/high is $0.370867997/$2.63000011.
Recent News
- BioMedNewsBreaks - AzurRx BioPharma Inc. (NASDAQ: AZRX) Enters Collaboration for Planned Phase 2 Clinical Trial of FW-1022
- BioMedNewsBreaks - AzurRx BioPharma Inc. (NASDAQ: AZRX) Announces Participation in BIO CEO & Investor Digital Conference
- Study Finds Post-Op Pain-Management Medication Doesn't Have to Include Opioids
Kaival Brands Innovations Group Inc. (KAVL)
The QualityStocks Daily Newsletter would like to spotlight Kaival Brands Innovations Group Inc. (KAVL).
Kaival Brands (OTCQB: KAVL), a company focused on generating shareholder value by incubating innovative products into mature and dominant brands within their respective markets, has announced that Bidi(R) Vapor has received a PMTA acceptance letter from the U.S. Food and Drug Administration (“FDA”). Kaival is the exclusive global distributor of Bidi Vapor LLC products. To view the full press release, visit https://ibn.fm/ba7Zx
Kaival Brands Innovations Group Inc. (KAVL) is focused on growing and incubating innovative and profitable products into mature, dominant brands. It aims to develop internally, acquire or exclusively distribute these products, helping them grow into market-share leaders by providing superior quality that is recognizable in their individual industries.
Formerly known as Quick Start Holdings Inc., the company changed its name to Kaival Brands Innovations Group Inc. (also known as Kaival Brands) in July 2019. Headquartered in Grant, Florida, the company commenced business operations on March 9, 2020.
Bidi™ Stick – Revolutionizing the Vaping Experience
On March 9, 2020, Kaival Brands entered into a partnership with Bidi Vapor LLC. The latter granted Kaival Brands exclusive global distribution rights for the innovative Bidi™ Stick.
Bidi™ Stick is a completely self-contained disposable product that is tamper-proof and recyclable. The innovative product is made from high-quality components and equipped with a long-lasting battery and class A nicotine. Its product engineering also includes a sensitivity control system, along with a proven mechanism designed to help identify and eliminate counterfeit products.
Available in 11 flavors, the Bidi™ Stick offers a premium vaping experience for adult consumers only. From its packaging design to its marketing strategies, Bidi Vapor makes sure that everything is compliant with government regulations.
On March 31, 2020, Kaival Brands partnered with QuikfillRx Digital as a digital service provider to help promote and commercialize the Bidi™ Stick. As a direct result of the partnership, Kaival Brands received back-to-back orders for the vaping device, totaling approximately $135,000, from sizable national convenience chains.
On September 8, 2020, the company announced that Bidi Vapor had submitted its Premarket Tobacco Product application (PMTA) to the U.S. Food and Drug Administration (FDA) for review. In total, over 285,000 pages of research, studies and surveys were submitted to support the application of Bidi™ Stick’s 11 variants.
“We are confident that, upon review, the FDA will authorize Bidi Vapor’s Bidi™ Stick for continued marketing in the United States,” Niraj Patel, President and CEO of Kaival Brands, stated in a news release (http://nnw.fm/unAyG).
Bidi Vapor is an industry leader in recycling – a position that was furthered through the creation of the Bidi Cares Initiative. The program encourages users to recycle their used Bidi™ Sticks instead of trashing them. As motivation, Bidi Vapor offers a free Bidi™ Stick for every 10 used devices recycled by a consumer. Kaival Brands is the exclusive recycling provider for the initiative.
Partnership Impact and Market Outlook
Bidi Vapor is a related party to Kaival Brands, as it is owned by Kaival Brands CEO Nirajkumar Patel. Patel is also the majority stockholder of Kaival Brands, placing both entities under common control.
The partnership has already had a positive impact on Kaival Brands, helping the company expedite growth, as evidenced by its Q2 financial results. According to Kaival Brands’ consolidated fiscal results for the quarter that ended on April 30, 2020, its revenues grew to approximately $22.5 million from no revenue in the same quarter of 2019. The company also scored a gross profit of $4.2 million for the three-month period. Net income was reported at $2.8 million for the quarter, compared to a net loss of about $4,000 in the second quarter of 2019. The company ended the second quarter of 2020 with a cash balance of $2 million (http://nnw.fm/44sq4).
The positive results are primarily an effect of Bidi™ Stick distribution amid the growing worldwide demand for high-quality vape products, as Patel explained in a news release. “Our focus now is to continue to increase revenues by increasing Bidi Vapor’s market share in the vaping industry,” he added.
Internationally, Kaival Brands has already taken steps to expand distribution of the Bidi™ Stick into Guam, Canada, the European Union, the United Kingdom, Australia and New Zealand.
To this end, the company has set up a market engagement and sales force to reach a higher volume of retail and wholesale customers. It also created a dedicated customer support team to provide high-quality service and an enhanced customer experience.
Kaival Brands is dedicated to developing innovative and viable options for adults who use tobacco and vape products and want a premium experience. The company wants to set higher standards to transform perceptions and elevate consumer experience in the vape and CBD industries, with a goal of increasing market share in the ever-growing vaping industry. In 2019, the reported global market for the vaping industry alone was $12.4 billion. These forecasts indicate a potential CAGR of 23.8% through 2027.
Cancellation of 300 Million Shares of Common Stock
In August 2020, the company canceled 300 million shares of common stock, marking a 52.1 percent reduction in its issued and outstanding shares of common stock (http://nnw.fm/W7s9T). Currently, the company’s outstanding common shares total 277,282,630. The cancelation was done in exchange for three million shares of Series A Preferred Stock. The Series A Preferred Stock cannot be converted before November 2023, barring any event that may trigger early conversion.
According to Patel, this move will benefit all shareholders and help maintain stability of the market pricing of remaining common stock. The overall goal is to increase value for long-term investors.
Management Team
Nirajkumar Patel is the CEO, CFO, President, Treasurer and Director of Kaival Brands and owner of Bidi Vapor LLC. In 2004, Patel received a Bachelor of Science in pharmaceutical sciences from AISSMS College of Pharmacy in Prune, India. He moved to the United States in 2005, and he continued his education at the Florida Institute of Technology, where he graduated in 2009 with a master’s degree in medicinal and pharmaceutical chemistry. He currently holds a Six Sigma Black Belt Certification.
Eric Mosser is the COO, Secretary and Director of Kaival Brands. Mosser attended Arizona State University, where he studied business management. In 2004, he graduated from Rio Salado College with an associate degree in applied science in computer technology.
Kaival Brands Innovations Group Inc. (KAVL), closed Tuesday’s trading session at $3.25, up 28.4585%, on 1,136,026 volume. The average volume for the last 3 months is 701,540 and the stock's 52-week low/high is $0.011199999/$3.65000009.
Recent News
- InvestorNewsBreaks - Kaival Brands Innovations Group Inc. (KAVL) Announces Bidi Vapor Received FDA PMTA Acceptance Letter for all 11 Bidi Stick Products
- InvestorNewsBreaks - Kaival Brands Innovations Group Inc. (KAVL) Enters Strategic Agreement with Potential to Triple Its Distribution Points
- InvestorNewsBreaks - Kaival Brands Innovations Group Inc. (KAVL) Announces New Bidi Pouch Product
GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF)
The QualityStocks Daily Newsletter would like to spotlight GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF).
GoldHaven Resources (CSE: GOH) (OTCQB: ATUMF) (FSE: 4QS), a Canadian junior exploration company active in the Maricunga Gold Belt of Northern Chile, has announced the appointment of Chris Ford to the company's advisory board; Ford will be a significant contributor to the company’s Chilean operations. Also today, the company was featured in a publication from MiningNewsWire, examining how, GHVNF today announced that the drill crew has been mobilized over the weekend and has commenced its 5,000-meter Phase I drill campaign starting at Rio Loa. To view the full press release, visit https://ibn.fm/bYabU. Additionally, the company was featured in a MiningNewsBreaks from MiningNewsWire, examining how shares in various Canadian silver mining firms recorded double-digit surges as the price of the metal increased to eight-year highs. Some credit the increment to promotional discussions on social media sites such as Reddit.
GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) (formerly Altum Resources Corp.), a Canada-based company engaged in the business of acquiring and exploring mineral resource properties, recently announced its entry into agreements to acquire seven advanced gold projects in the Maricunga Gold Belt of Chile that hosts over 100 million ounces of gold within the last 10 years.
Chilean Gold Properties Being Acquired
On April 17, 2020, GoldHaven Resources entered into an agreement to purchase a 100% interest in two gold projects located in the Maricunga Gold Belt of Northern Chile. The first property, Rio Loa, is located 25 kilometers south of Gold Fields Ltd.’s Salares Norte, where, this year, a five-million-ounce discovery was made. The second property, Coya, is located only 10 kilometers east of the Kinross La Coipa open pit mine, which has produced over 7.5 million ounces of gold to date.
Rio Loa Project
Initial geophysical studies of the Rio Loa site have exposed highly anomalous ardennite and lead values, a key characteristic of gold mineralization within silicified resistive bodies. The studies have also produced initial findings which are similar to those seen at contiguous mines, such as Salares Norte (operated by Gold Fields), which has over five million ounces in estimated gold deposits.
The potential economics for the site look particularly promising when taking the unit costs at the neighboring Salares Norte mine into account. Gold Fields has estimated that its production AISC (all-in sustainable costs) will approximate $552 per ounce and have forecast a 2.3-year payback period for its initial investment, assuming a $1,300 per ounce gold price.
Coya Project
The Coya site is located within close proximity to one of the richest and largest epithermal gold and silver districts in Chile and is in close proximity to active mining sites, specifically the La Coipa mine owned by Kinross. A study carried out in 2017-2018 on the Coya site of 796 rock chip samples found favorable gold and silver values, in some cases ranking as high as 764 grams/tonne of gold and 719 grams/tonne of silver – values which are near certain indicators of potential gold and silver deposits. The La Coipa mine (Kinross) has produced over 6.9 million ounces of gold to date.
On August 11, 2020, GoldHaven Resources acquired five potential gold projects in the Maricunga Gold Belt of Northern Chile. The Maricunga hosts discoveries within the last 10 years of over 100 million ounces of gold and over 450 million ounces of silver. These newly acquired properties are in close proximity to seven other mines, which possess an estimated aggregate of 81 million ounces of gold in total reserves.
GoldHaven’s five new projects cover a total area of approximately 22,600 hectares, or 226 square kilometers, located in the northern portion of the Maricunga Belt in proximity to the 5 million-ounce gold equivalent Salares Norte project owned by Gold Fields. Gold Fields announced in April 2020 its intention to proceed with the development of Salares Norte at a cost of $860 million, with a $138 million expenditure budgeted for 2020.
The Maricunga Belt extends approximately 150 kilometers north-south and 30 kilometers east-west, straddling the border between Chile and Argentina. This region hosts known mineral resources of more than 100 million ounces of gold, 450 million ounces of silver and 1.3 billion pounds of copper.
The Maricunga project’s opportunity came about as a result of a $150 million initiative launched by the Chilean Economic Development Agency (“CORFO”), with the objective of encouraging exploration and mining prosperity in Chile and strengthening Chile’s position as a world leader in the sector.
As part of CORFO’s program, a total of $15.3 million was given to private equity fund IMT Exploration to evaluate 403 projects, beginning in 2011. This led to a generative program carried out from 2016 to 2019, resulting in 126 potential epithermal targets from which 57 field evaluations were made. Due diligence work followed on 19 of these. Work programs were then conducted, including geological mapping, rock and soil sampling and TerraSpec (PIMA) analyses on geochemical grids for alteration mapping, and, as a result, the five high-priority Maricunga projects were identified. No drilling has been carried out on any of the Maricunga projects.
Securing Financing for Upcoming Operations
In conjunction with its announcement regarding its acquisition of five Chilean mining interests, GoldHaven Resources also detailed plans for a non-brokered private placement of 11.5 million units at a price of $0.35 per unit, for gross proceeds of $4,025,000. Each unit will consist of one share of the company and one warrant, the latter of which can be exercised to acquire an additional share of the company for a period of 18 months from the date of issuance at a price of $0.50 per share. Net proceeds from the offering are intended to be used to fund general expenses, as well as exploration and drilling of its mineral properties.
Gold Prices Hit Record High in 2020
Gold prices have been on a remarkable run in 2020, breaking above $2,000 per ounce for the first time on record. Having begun the year at $1,515 per ounce, the precious metal has seen a huge surge on the back of widespread economic uncertainty stemming from governments’ worldwide propensity to expand the money supply, from the reduction of the value of the U.S. dollar as expressed by the decrease in the U.S. dollar index, and from the very real economic effects of the COVID-19 pandemic.
Global central banks have carried out 144 interest rate cuts thus far in 2020, reducing rates by a cumulative 5,035 basis points (http://nnw.fm/jzZt0). Meanwhile, the IMF has estimated that global governments have introduced fiscal support measures amounting to over $9 trillion since the start of the pandemic (http://nnw.fm/Or9rI). The resulting weakness in the U.S. dollar and eventual inflationary pressures stemming from these measures has prompted a number of investment banks to boost their near-term outlooks for gold prices, with Bank of America raising its 18-month gold price target to $3,000 per ounce (http://nnw.fm/PQJtc).
Leadership Team
David Smith, President, CEO and Director, has been immersed in the mining industry for the last eight years, working in corporate development and finance. Prior to GoldHaven Resources, Smith cofounded a multifaceted real estate development and sales company, which has now been in operation for over 35 years. He also cofounded two successful environment-focused companies listed on the Toronto Stock Exchange. Both companies were sold independently and returned a significant profit for shareholders.
Darryl Jones, Chief Financial Officer, is a finance executive and CPA with over 30 years of public company and project buildout experience. Most recently, Jones served as the CFO of Lupaka Gold Corp., retiring in June 2018. Prior to that, Jones serves as CFO of Corriente Resources, which was sold to CRCC-Tongguan in May 2010 for C$680 million.
Patrick Burns, VP Exploration and Director, is a Canadian geologist with over 40 years of experience throughout the Caribbean and Central and South America. He played a direct role in the discovery of the Escondida porphyry copper deposit in Chile and has been involved in publicly traded mining companies, predominantly in Chile, for 35 years.
Marla Ritchie, Corporate Secretary, brings over 25 years of experience in public markets to the GoldHaven team. Throughout this time, she has worked as an administrator and corporate secretary specializing in resource-based exploration companies. Currently, Ritchie is the corporate secretary for several companies, including International Tower Hill Mines Ltd. and Trevali Mining Corp.
Gordon Ellis, Director; has over 50 years’ experience in mining and resource development. A professional engineer and entrepreneur, he has held multiple senior management and director roles with public mining companies, as well as a multi-billion-dollar ETF fund. Ellis holds an MBA in international finance and a Chartered Directors designation.
Scott Dunbar, Director is a professor and head of multiple departments at the University of British Columbia, including mineral extraction and mining innovation, as well as mining engineering. He has been involved in projects around the world in regard to mining exploration, geotechnical engineering and mine design. Dunbar received his PhD in geophysics and civil engineering from Stanford University.
GoldHaven Resources Corp. (OTCQB: GHVNF), closed Tuesday’s trading session at $0.7136, off by 0.888889%, on 127,809 volume. The average volume for the last 3 months is 104,604 and the stock's 52-week low/high is $0.109999999/$0.83069998.
Recent News
- GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS) Fortifies Leadership Team, Commences Drilling and Further Exploration Campaigns
- MiningNewsBreaks - GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS) Commences Phase I Drill Campaign at Rio Loa
- Canadian Silver Mining Futures Jump Courtesy of Social Media Discussions
Net Element (NASDAQ: NETE)
The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).
Net Element (NASDAQ: NETE) was featured today in a publication from Green Car Stocks, examining how when you’re driving a conventional internal combustion engine (“ICE”) car, going for a long drive or even taking an interstate road trip isn’t a hassle. All you have to do is plan a route to your destination, and you’re ready to hit the road. But for EV drivers, things get a little complicated. Although electric vehicles produce minimal emissions and are cheaper to fuel and maintain over their lifetimes, finding a reliable public charger while on the road can be quite a hassle.
On June 15, 2020, Net Element announced its entry into a binding letter of intent to merge with privately-held Mullen Technologies Inc., a Southern California-based electric vehicle company, in a stock-for-stock reverse merger in which Mullen’s stockholders will receive the majority of the outstanding stock in the post-merger company. The proposed merger is currently pending the execution of a definitive agreement, shareholder vote and regulatory approval.
Net Element Inc. (NASDAQ: NETE) is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce and mobile devices. The company operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets.
Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. The company’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.
Net Element has also launched a blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.
“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element chairman and CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”
Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.
Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:
- Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
- Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
- Payonline – A fully integrated, processor agnostic electronic commerce platform.
Net Element is ranked on Deloitte’s Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies in both 2017 and 2018, during which the company grew 190 percent and 183 percent, respectively. The company credits its progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.
Net Element was also listed among South Florida Business Journal’s 2016 fastest growing technology companies.
Leveraging its suite of application performing interfaces (APIs) and connectors, Net Element powers commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.
Leading this innovation is chairman and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jeffrey Ginsburg, CPA, and Steven Wolberg, the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.
From mobile payments and value-added transactional innovations like Aptito to e-commerce and retail payment transaction processing brands like Payonline and Unified Payments, Net Element is transforming the online and mobile experience.
Net Element (NETE), closed Tuesday’s trading session at $14.54, up 2.0351%, on 693,414 volume. The average volume for the last 3 months is 2,332,719 and the stock's 52-week low/high is $1.472/$20.0783996.
Recent News
- Google Maps Tweaks Functionality with EV Drivers in Mind
- AI Could Help Find EV Charging Infrastructure Gaps by Reading User Reviews
- GreenCarNewsBreaks - Net Element Inc. (NASDAQ: NETE) Working Diligently to Finalize Merger, Capitalize on Growing EV Sector Demand
Predictive Oncology (NASDAQ: POAI)
The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).
Predictive Oncology (NASDAQ: POAI) was featured today in a publication from BioMedWire, examining how patients suffering from potentially fatal diseases, such as cancer, may often undergo weeklong gaps that are discomforting when their courses of treatment begins. Doctors use this period to learn whether a patient’s treatment is working, and while it’s the standard way of doing things, the approach prevents health-care professionals from tracking the disease’s progression in real time.
Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.
Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:
- A database of clinically validated historical and outcome data from patient tumors
- An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
- A “smart” patient-derived tumor profiling platform
- An in-house bioinformatics artificial intelligence (AI) platform
- A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
- An FDA-approved fluid collection and disposal system
Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.
Subsidiaries
Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.
Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.
In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.
TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.
Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.
The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.
Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.
Competitive Advantage
Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.
Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.
Leadership Team
Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.
CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.
Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.
Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.
Predictive Oncology (POAI), closed Tuesday’s trading session at $1.65, up 3.7736%, on 4,691,977 volume. The average volume for the last 3 months is 2,622,772 and the stock's 52-week low/high is $0.629999995/$4.42000007.
Recent News
- Biological Sensors May Provide Physicians with Insights on Whether Treatments Are Effective
- Predictive Oncology Inc. (NASDAQ: POAI) Stands to Benefit from Explosive Growth of Precision Medicine
- BioMedNewsBreaks - Predictive Oncology Inc.'s (NASDAQ: POAI) Helomics Launches Project Focused on Ovarian Cancer Utilizing Proprietary PeDAL(TM) Platform
SRAX Inc. (NASDAQ: SRAX)
The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).
SRAX Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, has announced the reconstitution of its LD Micro Index. The announcement included impressive numbers that indicate the index’s growth: in 2020, the LD Micro Index was up 35.72%, and as of market close on Feb. 5, 2021, growth for this year was 34.21%. The LD Micro Index, which includes 1,189 companies, employs a mixture of screening for inclusion and manual exclusion on its selection of microcap North American companies. To view the full press release, visit http://ibn.fm/WkxA1
SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.
Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.
SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.
SRAX Verticals
- SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
- SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
- SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
- SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
- SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
- SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.
BIGtoken
BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.
The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.
Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.
Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.
SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.
International Expansion
BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.
The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.
SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.
BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.
Leadership
Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.
Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.
SRAX Inc. (NASDAQ: SRAX), closed Tuesday’s trading session at $5.68, up 9.6525%, on 1,860,701 volume. The average volume for the last 3 months is 442,495 and the stock's 52-week low/high is $1.50999999/$5.98999977.
Recent News
- InvestorNewsBreaks - SRAX (NASDAQ: SRAX) Announces LD Micro Index Reconstitution, Index Adds 423 Companies
- SRAX Inc.'s (NASDAQ: SRAX) Sequire Provides Public Companies with Actionable Insights on Investor Activity While Severe Volatility Grips Markets
- InvestorNewsBreaks - SRAX (NASDAQ: SRAX) Sequire Platform Now Has 3M-Plus Retail Investors
Green Hygienics Holdings Inc. (OTCQB: GRYN)
The QualityStocks Daily Newsletter would like to spotlight Green Hygienics Holdings Inc. (OTCQB: GRYN).
Green Hygienics Holdings Inc. (OTCQB: GRYN) was featured today in the 420 with CNW by CannabisNewsWire. Jazz Pharmaceuticals (NASDAQ: JAZZ), a global pharmaceutical company, has come to an agreement to acquire GW Pharmaceuticals (NASDAQ: GWPH) for $7.2 billion in stock and cash. GW Pharmaceuticals, which is based in the United Kingdom, is one of the biggest medical cannabinoid businesses globally.
Green Hygienics Holdings Inc. (OTCQB: GRYN) is a California-based innovative technology-driven enterprise focused on the high standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids.
The company aims to be a leader in compliance and capabilities in the hemp and cannabinoid supply marketplace. By leveraging state of the art technologies, the company intends to open up a whole new world of novel cannabinoids and targeted bio-delivery technologies never before explored, solving the issues of stability, pharmacokinetics, biological tissue penetration and bioavailability.
Dedicated to creating the hemp industry’s safest and finest quality products, the company will be uniquely positioned to deliver product efficacy and supply chain solutions to consumers, as well as to leverage these within its own products and brand portfolio.
USDA Organic Certification and FDA Registration
On August 26, 2020, Green Hygienics registered with the U.S. Food and Drug Administration pursuant to the Federal Food Drug and Cosmetic Act, as amended by the Bioterrorism Act of 2002. This registration strengthens the company’s core mission to provide product efficacy to the pharmaceutical industry and consumers alike.
On September 30, 2020, Green Hygienics was granted USDA Organic Certification (7 CFR Part 205) for the cultivation and post-harvest processing of industrial hemp by the California Certified Organic Farmers for its Sol Valley Ranch property. This certification further enables the company to supply certified organic hemp products to national and international markets.
Market Opportunity
Green Hygienics is focused on finding, acquiring and developing strategically positioned businesses, as well as the best innovations within the hemp industry – a fast-progressing market with remarkable opportunities for growth. The industrial hemp market is expected to reach $5.33 billion in 2020 and is projected to rise to $15.26 billion by 2027, achieving a CAGR of 15.8%, per Grand View Research.
Capital Structure
GRYN has less than 42 million shares outstanding, fully diluted. The company has just 7.2 million common shares in float and boasts a balance sheet with no toxic debt or overhang.
Key Management
Dr. Levan Darjania serves as the company’s Chief Science Officer. Darjania has over 26 years of experience in biotechnology and pharmaceutical drug development. His research and development experience has led him to develop many in-house and collaborative R&D programs over the course of his career.
Kyle MacKinnon serves as GRYN’s Chief Operating Officer. He has extensive knowledge in cannabis processing and was previously the Business Development Manager of Advanced Extraction Systems Inc., a leader in CO2 Supercritical Fluid Extraction. MacKinnon brings over 20 years of sales and management experience to the company.
Ronald Loudoun is the President, CEO, Secretary and Director of Green Hygienics. He received an undergraduate business degree from the British Columbia Institute of Technology. Before joining Green Hygienics, he was the founder and a director of renewable energy firm Archer CleanTech Inc.
Jerry Halamuda is the Senior Vice President of Business Development of the company’s Agriculture Division. He has an extensive career working in the agriculture and horticulture industry. Halamuda has founded, managed and operated multiple successful companies, including Color Spot Nurseries.
John Gildea is GRYN’s Senior Vice President of Corporate Development. He has over 20 years of experience working within the private and public markets. His expertise includes negotiating and structuring private and public financing and mergers. During the course of his work, Gildea has established trusted relationships with a network of equity and capital partners.
Green Hygienics Holdings Inc. (OTCQB: GRYN), closed Tuesday’s trading session at $0.97, off by 13.3929%, on 84,116 volume. The average volume for the last 3 months is 25,856 and the stock's 52-week low/high is $0.300000011/$1.89999997.
Recent News
- 420 with CNW - Jazz Pharmaceuticals (NASDAQ: JAZZ) to Acquire GW Pharmaceuticals (NASDAQ: GWPH) for $7.2 Billion
- CannabisNewsBreaks - Green Hygienics Holdings Inc. (GRYN) Partners with Massive Media, GG Marketing LLC as Part of Strategic 2021 Sales and Marketing Plan
- HempNewsBreaks - Green Hygienics Holdings Inc. (GRYN) Continues Build Out of Highly Differentiated Business Model
InsuraGuest Technologies, Inc. (TSX.V: ISGI) (OTC: ISGIF)
The QualityStocks Daily Newsletter would like to spotlight InsuraGuest Technologies, Inc. (TSX.V: ISGI) (OTC: ISGIF).
InsuraGuest Technologies (TSX.V: ISGI) (OTCQB: ISGIF), a leader in the insurtech sector (insurance + technology), recently marked another major milestone in its mission to revolutionize the insurance industry. InsuraGuest is disrupting status quo insurance markets by leveraging its proprietary software platform to deliver digital insurance products that provide better benefits at lower costs across multiple industry sectors. One of the initial primary targets is the hospitality industry and recent news from InsuraGuest marks a new milestone in the company’s reach and scope of business in the hospitality sector.
InsuraGuest Technologies, Inc. (TSX.V: ISGI) (OTC: ISGIF) is a leading global SaaS (Software-as-a-Service) company leveraging its proprietary, flagship insurtech (insurance + technology) software, InsuraGuest, which is integrated with the property management systems of hotels and vacation rentals to deliver custom Hospitality Liability coverages.
InsuraGuest’s Hospitality Liability coverages are purchased by hotels and vacation rental properties, which can address claims from guests and their room occupants. The combination of the integrated software and customized insurance provides the property liability coverages the guests benefit from in the event a loss is incurred during their stay.
The Hospitality Liability policy is offered through integration of InsuraGuest’s API with the clients’ property management systems. InsuraGuest’s platform is currently capable of integrating with approximately 71 different hotel and vacation rental property management systems, giving it access to millions of rooms worldwide.
InsuraGuest continues to pursue expansion opportunities in the United States, and has plans to expand to its distribution platform and Hospitality Liability coverages to the United Kingdom and Europe regions by third quarter 2020, as well as expansion into Asia by the end of 2020.
Protection that Enhances the Guest’s Experience
InsuraGuest’s Hospitality Liability coverages add a layer of protection for the property on a primary basis, should a guest experience an accident or theft while staying at an InsuraGuest member hotel or vacation rental property.
Market Opportunity
The U.S. hotel industry generated more than $218 billion in annual revenues in 2018, an increase of $10 billion from the previous year, according to STR’s 2019 HOST Almanac. The European market is more than double the size of the U.S. market. According to Oxford Economics, there were 6.4 billion nights stayed in the world, with 2.6 billion hotel nights stayed in Asia, 2.8 billion nights stayed in Europe, and 1.1 billion stayed nights in the United States. Additionally, $100 billion was spent on vacation rentals in the United States, where there approximately 4.5 million second homes are being managed by a third-party rental company.
With distribution in Europe and the United States, InsuraGuest’s combined demographics will total 3.9 billion nights stayed, and will more than double its vacation rental opportunities.
Within this burgeoning, high-demand industry is risk of liability to guest injury. For example, gym injuries are among the top five most common hotel accidents. Without proper hedges in place, the property may be liable in a personal injury claim or lawsuit that are not the properties fault.
Though the potential for accidents, slip and falls and mishaps can be widespread, it can be covered under the InsuraGuest Hospitality Liability policy to provide guests a worry-free and enjoyable stay that potentially increases loyalty for the property.
Investment Consideration
- Targeting hotels and vacation rentals, a multi-billion-dollar industry
- Providing the first line of defense in case of accident, loss or death
- Expanding distribution reach with footing in European hotel and vacation rental markets
- Expansion into Asia by 2020
Executive Team
Douglas Anderson, Chairman & Chief Executive Officer
Douglas Anderson has been a businessman in the real estate industry for nearly 30 years. His business expertise includes master planning and development implementation for larger-scale resorts, business parks and commercial developments across the USA and two provinces in Canada. His business endeavors include the founding of the 7th larger private equity fund in America focusing on multifamily and senior care (ROC Fund/Bridge IPG Fund). He serves as chairman/founder of a golf and winter sports ski holding company with operations in four major east coast markets and British Columbia, Canada.
Anderson earned a Bachelor of Science in consumer studies with an emphasis in architecture as an undergraduate at the University of Utah. He subsequently earned his MBA. He also attended a three-year OPM Program a postgraduate business education at Harvard Business School in Boston. Anderson is an avid skier and outdoor enthusiast.
Logan Anderson, CFO & Director
Logan Anderson (bachelor’s degree in communications, accounting and economics) holds the designation of ACA with the Chartered Accountants of Australia and New Zealand. He began his career as an associate chartered accountant in New Zealand and then Canada. This was followed by his position as controller of a management services company which was responsible for the management of numerous private and publicly traded companies. Since 1993, Anderson has served as president of Amteck Financial Corp. (and its predecessors), a private financial consulting services company servicing both private and public companies. He is a former director of 3D Systems, Inc. (NYSE: DDD), and was formerly a founder, officer, and director of Worldbid.com. Anderson has also been involved in raising funds for numerous private and public companies in all stages of their development and has been an officer and director for numerous public and private companies over the past 40 years.
Charles James Cayias, President & Director
Charles James Cayias is also the president and owner of Charles James Cayias Insurance Inc. He is a third-generation insurance professional whose creativity and artistic vision have enabled him to establish a full-service agency combined with the personal service each client deserves. His outstanding people skills, honesty, integrity and fairness are evident by his loyal and growing clientele, the majority of which are referrals who become long-time customers and friends. Cayias began his insurance career in the early 1970s and has been licensed since 1977. He is licensed in all 50 states and specializes in niche programs. He has extensive expertise in all aspects of the insurance industry including commercial insurance, employee benefits, workers’ compensation, professional liability, risk management and bonding.
Tony Sansone, COO & VP of Finance
Tony Sansone has over 30 years of financial, operations and business development experience which includes serving as CFO in the health care, foodservice distribution, manufacturing and technology sectors, including public company experience. He has held senior finance positions in the banking, telecommunications, medical products, and food & drug retailer industries, closing over $430 million of private debt, equity and line of credit financings and over $350 million of a merger, acquisitions, real estate and state incentive transactions, including due diligence, negotiations, closing, and integration. Sansone coordinated and was the executive sponsor for four ERP implementations and multiple other best-in-class software & technology solutions. He received his MBA from the University of Utah and a Bachelor of Science in accounting from Utah State University. Sansone also currently serves as president-elect of the Utah Chapter of Financial Executives International and a past president and current member of the board of trustees for Catholic Community Services of Utah. He is the proud father of three children.
Christopher J. Panos, Vice President & Director
Christopher J. Panos is a highly competitive sales professional with over 15 years of territory manager sales experience and an award-winning record of achievements. He is exceptionally well organized with a proven work history that demonstrates self-discipline, superb communication skills, and the initiative to achieve both personal and corporate goals. Panos is successful in building relationships with a large network of industry professionals in order to grow and maintain new and existing business, exceed new sales objectives and provide in-depth product training to authorized dealers and sales personnel.
Alexander Walker III ESQ, Corporate Counsel & Director
Alexander Walker III ESQ has served as director of the company since September of 2018 and as counsel to the company since July of 2018. Walker is an attorney and has been a member of the Utah Bar Association since 1987 and a member of the Nevada State Bar since 2003. His practice has involved general business litigation, in both federal and state courts, and transactional work, including securities offerings and registration, corporate formation and periodic reporting compliance. Walker has provided legal services to emerging businesses throughout his carrier and at times has served as an officer and board member as well as legal counsel public companies. His duties as legal counsel for a public company engaged in the business of ownership and operation of coal-producing properties in the western United States included oversight of corporate-related legal matters including securities reporting, corporate compliance, federal and state mining regulation, and employment law oversight. He also has served as the chair of the Mining Committee of the Energy, Natural Resources and Environmental Law Section of the Utah State Bar, a member of the board of directors of the South East Utah Energy Producers Association, the co-chair of the board of the Western Energy Training Center, a board member of the Utah Supreme Court Committee to Review the ABA Recommendations Regarding the Office of Professional Conduct, and a board member of the University of Utah Crimson Club.
Jennifer Epperson, Vice President of Sales
Jennifer Epperson has over 20 years of B2B sales experience with exceptional success history. She has grown and developed sales territories across multiple industries. Her ability to find and develop strategic relationships has given her top-level performance throughout her career. Epperson’s passion and knowledge provide an inherent ability to connect and retain relationships for the growth of the company. Throughout her professional career, she has achieved peak performance sales results and awards year after year. She captures the vision of the company and drives it forward with enthusiasm and expertise. Her commitment to providing an exceptional customer experience has been the key to her success.
Richard Matthews, Interim Financial Controller
Richard Matthews joined the InsuraGuest team in March 2019 as the interim financial controller. Leading the Finance and Audit team, Matthews is responsible for the delivery of financial services such as accounting, treasury, reporting, budgeting and insurance management, in accordance with legislative requirements and organizational policies and strategies. He has over 30 years of experience in providing professional services across a broad range of finance areas including compliance, business process, audit, and financial reporting. He holds a degree in accounting from the University of Utah and is a licensed CPA in the state of Utah.
Roger Bloss, Corporate Consultant & Board Advisor
Roger Bloss joined InsuraGuest in August of 2019 to advise the company and its board on hotel transactions, contributing his knowledge from more than 40 years in the hospitality industry. Bloss previously served in executive positions with several major hotel franchise companies and in 1996 founded Vantage Hospitality Group hotel brands. Under his leadership, Vantage became a Top 10 global hotel company and made the Inc. 500/5000 list of Americas’ fastest-growing private companies for eight straight years. Bloss was named Lodging Magazine’s “Innovator of the Year” in 2006 and 2010, and in 2009 earned a spot on HSMAI’s “Top 25 Extraordinary Minds in Sales and Marketing.” Bloss joined Red Lion Hotels Corporation (RLHC) in September 2016 in conjunction with the acquisition of Vantage.
Jim Kilduff, Board Advisor
James “Jim” C. Kilduff has nearly 40 years of experience in the insurance and risk management sectors. He is a dynamic and energetic team leader and builder with extensive experience in the changes affecting the insurance business through Gas, alternative distribution, insurtechs and program business. His skillset includes experience as chief insurance officer with Outdoorsy Insurance Group, CEO with Harbor Hill Solutions Inc., and senior vice president and chief marketing officer with State National Insurance Companies. His career has spanned MGA creation and management, insurance company management, business development and underwriting, primary insurance and reinsurance.
Don Archibald, Board Advisor
Don Archibald brings to InsuraGuest’s advisory board 54 years of experience as an insurance agent. Archibald is the founder and former owner of Archibald Clarke and Defieux (ACD Insurance), as well as the co-founder and former equity partner of Sussex Insurance, and an agent with Sussex since 2014.
InsuraGuest Technologies, Inc. (ISGIF), closed Tuesday’s trading session at $0.20235, off by 1.0165%, on 5,880 volume. The stock's 52-week low/high is $0.079300001/$0.248799994.
Recent News
- InsuraGuest Technologies, Inc. (TSX.V: ISGI) (OTCQB: ISGIF) Marks New Milestone in Industry Disruption
- InvestorNewsBreaks - InsuraGuest Technologies Inc. (TSXV: ISGI) (OTCQB: ISGIF) Renews Annual Contract with Wintergreen Resort
- InvestorNewsBreaks - InsuraGuest Technologies Inc. (TSXV: ISGI) (OTCQB: ISGIF) Announces OTCQB Listing, DTC Eligibility
HempFusion Wellness Inc. (TSX: CBD.U) (FWB: 8OO) (OTC: CBDHF)
The QualityStocks Daily Newsletter would like to spotlight HempFusion Wellness Inc. (TSX: CBD.U) (FWB: 8OO) (OTC: CBDHF).
HempFusion Wellness (TSX: CBD.U) (OTC: CBDHF) (FWB: 8OO), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, today announced that its Chief Marketing Officer, Ola Lessard, was elected president of the U.S. Hemp Roundtable for a second consecutive term. The “Roundtable” is one of the most influential non-profit organizations advocating for national hemp legislation in the United States. To view the full press release, visit: https://www.cnw.fm/O7x11
HempFusion Wellness Inc. (TSX: CBD.U) (FWB: 8OO) (OTC: CBDHF) is a leader in the health and wellness CBD industry, providing innovative and diversified proprietary formulations utilizing the power of whole-food hemp nutrition.
Invested heavily in regulatory compliance, HempFusion aims to consistently meet and even exceed the high standards required by retailers and consumers – putting safety, quality and consistency first. In support of these efforts, the company is U.S. Hemp Authority Certified and is a current board member of the U.S. Hemp Roundtable, a coalition of leading companies committed to advancing safe hemp and CBD products.
HempFusion reported 1,750 shareholders and $18.3 million in cash as of June 30, 2020 – the second-largest cash position in its sector – with no debt. Looking ahead, the company is currently preparing to launch an IPO directly onto the Toronto Stock Exchange (“TSX”) senior board, where it has already reserved ticker symbol ‘CBD.U’. Learn More About HempFusion Upcoming IPO.
HempFusion is headquartered in Denver, Colorado.
HempFusion’s Proprietary Wellness Portfolio
The diverse product portfolio showcased by HempFusion includes 46 products that are currently on shelves. The company’s leading offerings include HempFusion-owned Biome Labs, HF Labs and Probulin. Due to the time and resources allocated to increasing the compliance of these proprietary products, HempFusion may have a competitive advantage and create additional retail opportunities that are not available for other CBD companies.
HempFusion’s Diversified Revenue Pipeline
HempFusion’s focus and investment into regulatory compliance has opened doors to major food and drug mass or big box retailers that are not available to other CBD companies. This strategic approach includes five distinct channels:
- Natural Health Retailers
- eCommerce
- Big Box / Food and Drug Mass
- Doctor Practitioner
- Convenience
HempFusion’s Line of Products
HempFusion’s branded line of products is based on the company’s proprietary Whole Food Panoramic Full-Spectrum Hemp Complex. Each product is condition-specific, targeting needs such as sleep, energy and stress.
All of HempFusion’s products are made from DNA-verified, European Union registered, non-GMO, organic industrial hemp. The company’s offerings span multiple product categories, including:
- Tinctures and capsules – These offerings make up the most popular product category in the $4 billion U.S. CBD market.
- OTC topicals – HempFusion is one of the few CBD companies marketing FDA Drug Listed Topicals. The FDA compliance standards ensure that these products meet the standards set by larger national retailers.
- Condition-specific OTC products – HempFusion has OTC products that are condition-specifically targeted, including:
- OTC Pain Products – The global pain relief market for topicals is projected to reach $13.3 billion by 2025, with a CAGR from 2018 to 2025 of 7.4%.
- OTC Eczema Products – The global dermatitis market is projected to reach $13.6 billion by 2026.
- OTC Acne and Aging/Beauty Products – The global market for beauty and anti-aging products is currently estimated at $1.08 trillion.
- OTC First Aid and Wound Healing Products – In 2019, the 10 top-selling first aid ointments in the United States generated over $650 million in sales.
Probulin Probiotics and Digestive Enzymes
Probulin Probiotics is a 100% wholly owned subsidiary of HempFusion Wellness Inc. and is currently one of the fastest growing probiotics brands in the United States, according to Spins syndicated data.
The Probulin product line addresses a wide range of consumer needs, including daily care, total care, women’s health and children’s products. The probiotics market represents a growing opportunity, as it is estimated to reach $7 billion globally by 2022.
Because of the diverse offerings of the Probulin line, it serves as HempFusion’s gateway to retailers who may not currently carry CBD products.
This ‘Trojan Horse Strategy’ is intended to allow the company to establish, develop and build relationships among these retailers. By achieving approved vendor status, the company may be able to facilitate faster onboarding times, enabling accelerated access to its CBD products in the future.
HF Labs and Biome Research – Doctor and Practitioner Product Lines
The HF Labs and Biome Research product lines are directed toward doctors and practitioners and cater to hospitals, compounding pharmacies and free-standing dispensaries. With an estimated target market of 28,000+ integrative medical doctors and 70,000+ licensed chiropractors in the United States, these offerings create a unique market opportunity as HempFusion continues to broaden its footprint in the CBD industry.
Research on CBD and Human Safety
HempFusion is one of 12 CBD companies selected to participate in ValidCare’s groundbreaking study regarding CBD and human safety, which is expected to be complete by the end of October 2020. The study is designed to address previous questions from the FDA regarding CBD products.
As part of this study, HempFusion and the other selected companies will be conducting human trials to determine if the daily use of full-spectrum hemp-derived CBD or CBD isolate impacts the human liver.
Management Team
Jason Mitchell, N.D., is the co-founder, Director and CEO of HempFusion. He has over 20 years of experience in the natural products industry and is a naturopathic doctor certified by the ANMCB. Mitchell received his doctorate from the Trinity College of Natural Health and is a member of the American Naturopathic Medical Association and the CNHP. He is an expert in supplemental formations and was responsible for successfully creating and launching over 300 industry-leading products during his 15-year tenure at Country Life Vitamins.
Ian DeQueiroz is the Chief of Brand Strategy & Partnerships and a Director for HempFusion. He is a serial entrepreneur with experience in early-stage cannabis and hemp companies. In 2010, he acquired his first cannabis CO2 extraction company in the United States. DeQueiroz has facilitated the licensing process for many companies in the United States, as well as one of Jamaica’s premier cannabis companies, Epican Medicinals Ltd.
Jon Visser is HempFusion’s Chief Revenue Officer. He has over 25 years of experience in all areas of sales and marketing, with a proven track record of consistently driving growth across all major channels. Visser was previously the Senior Vice President of Sales at Navajo Inc., a multi-national manufacturer/distributor of brands like Pennzoil Automotive Supplies, Piranha Eyewear and Navajo Inc., the largest distributor of trial- and travel-sized health and beauty products in the United States. Visser grew annual sales from $60 million to $128 million in less than three years while at Navajo Inc.
Bruce Valentine Jr. is the Chief Financial Officer of HempFusion. He has a proven track record working with high-growth companies and was named CFO of the Year in 2013 by the Northern Colorado Business Report. Valentine is the former CFO of Otter Products and has over 15 years of financial management experience.
Ola Lessard is the Chief Marketing Officer of HempFusion and is also the President of the U.S. Hemp Roundtable. She has experience in marketing creative and effective brand strategies. She is a former Vice President of Marketing at Barlean’s, an award-winning supplements provider based in Washington.
Nancy Angelini is the Director of the Doctor/Practitioner Channel. She has over 25 years as an active, licensed practitioner. Angelini travels the country as a lecturer and product manager. She is responsible for opening doors to some of the largest doctor/practitioner networks in the United States.
Daniel Brody is the Chief Corporate Officer of HempFusion. He is the co-founder and former Vice President of The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF). Brody has been instrumental in listing multiple world-class cannabis companies, including TGOD, Emblem Corp. and Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF). Before joining the cannabis industry, he spent seven years working at two leading Canadian brokerage firms.
HempFusion Wellness Inc. (CBDHF), closed Tuesday’s trading session at $2.49, up 5.4415%, on 131,664 volume. The average volume for the last 3 months is 127,250 and the stock's 52-week low/high is $1.65999996/$2.5999999.
Recent News
- HempNewsBreaks - HempFusion Wellness Inc. (TSX: CBD.U) (OTC: CBDHF) (FWB: 8OO) CMO to Serve 2nd Consecutive Term as President of US Hemp Roundtable
- CBD Market Steadiness Buoys HempFusion Wellness Inc. (TSX: CBD.U) (OTC: CBDHF) Hopes as TSX Launch Completed
- HempNewsBreaks - HempFusion Wellness Inc. (TSX: CBD.U) (OTC: CBDHF) (FWB:8OO) Announces US Symbol
Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2)
The QualityStocks Daily Newsletter would like to spotlight Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2).
Excellon Resources (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) today provided an update on ongoing exploration at the Platosa Project in Durango, Mexico, where four diamond drill rigs are currently active. "Exploration at Platosa continues to deliver compelling targets at a mine and regional level," said Ben Pullinger, SVP Geology and Corporate Development. To view the full press release, visit https://ibn.fm/M8pCn
Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) (“Excellon” or the “Company”) is a silver and base metals producer with precious metal exploration and development projects in Mexico, Idaho and Germany. Since being founded in 1987, the Company has been advancing a precious metals growth pipeline focused on creating wealth for its stakeholders by realizing strategic opportunities in the silver and gold markets.
Excellon is an active and influential member of the Mining Association of Canada (“MAC”). The Company implements a practical, best-in-class management system that addresses the safety, health, security, environmental and community aspects of its operations, per the UN Sustainable Development Goals. On each project, the Company incorporates MAC’s Towards Sustainable Mining Initiatives and other world-class best practices with the objective of constantly improving its safety systems, training and hazard recognition.
Precious Metals Growth Pipeline
The Company is advancing a precious metals growth pipeline that includes: Platosa, Mexico’s highest-grade silver mine since production commenced in 2005; Kilgore, a high-quality gold development project in Idaho with strong economics and significant growth and discovery potential; and an option on Silver City, a high-grade epithermal silver district in Saxony, Germany, with 750 years of mining history and no modern exploration.
Maintaining and developing this pipeline presents the Company with enhanced opportunities in the expanding precious metals market, which was valued at $193.3 billion worldwide in 2020 (https://nnw.fm/6nv5f). This market is expected to increase at a compound annual growth rate (“CAGR”) of 9% from 2020 to 2027, resulting in an estimated $362.1 billion market size in 2027 (https://nnw.fm/6nv5f). Global market demand was calculated at 22,581.8 tons in 2020 and is expected to grow to 36,501.1 tons in 2027, achieving a CAGR of 3.5% (https://nnw.fm/6nv5f).
Excellon reported strong results in terms of both production and average pricing at the end of Q4 2020, including:
- Silver – 355,581 oz – $24.46
- Lead – 2,223,465 lbs. – $0.87
- Zinc – 2,452,728 lbs. – $1.21
Compared to Q4 2019, Excellon’s silver production increased by 37%, lead increased by 32% and zinc increased by 19% in Q4 2020 (https://nnw.fm/4C0P7).
Platosa Mine – Silver, Lead, Zinc – Production, Development & Exploration
The Platosa Mine is located 5 km north of Bermejillo, Durango, Mexico, on a 14,000-hectare property. The mine commenced production in 2005 as an underground operation and is 100% owned and operated by Excellon. The Company is mining massive sulfide ores rich in silver, lead and zinc from a series flat-lying massive sulfide bodies (mantos) in a carbonate replacement deposit system. Historically, the mining method was a modified room and pillar method, which transitioned to cut-and-fill in recent years and overhand-cut-and-bench in 2020. The ore produced from the mine is transported 200 km south for processing at the Company’s 100% owned Miguel Auza mill.
Kilgore Project – Gold – Exploration & Resource Growth
The Kilgore Project is located in Clark County, situated in eastern Idaho in the United States. The project area is 100% owned and operated by Excellon. While still in the exploration and development phase, the primary target on the 13,627-acre site is an epithermal gold system. The property itself has historical mining that dates back to the 1930s, with modern mineral exploration beginning in the 1980s. The Kilgore Project displays characteristics similar to Kinross Gold’s Round Mountain Mine, which has produced more than 15 million ounces of gold since operations began in 1977.
Evolución Project – Mineral Processing, Resource Growth & Exploration
The Evolución Project is located in Miguel Auza, Zacatecas, Mexico, and hosts a large gold, silver, lead and zinc epithermal within a 45,000-hectare property that is 100% owned by Excellon. The site includes a processing facility with a mill and flotation circuit which processes ore from Excellon’s Platosa mine. The facility has a capacity of 800 tons per day, with a 650 ton-per-day ball mill in operation and a second 150 ton-per-day ball mill on standby. Excellon is looking at opportunities for toll milling, expansion and economic study of the mineral resource and grassroots exploration. Importantly, the project covers an unexplored 35-kilometer strike of the Fresnillo silver trend, the richest silver belt in the world.
Silver City Project – Exploration
Excellon holds an option to acquire the 16,400-hectare Silver City Project in Saxony, Germany. Initial drilling results in 2020 confirmed the presence of a high-grade, district-scale epithermal silver system over more than 12 kilometers of strike. The Company is now focused on defining wider zones of mineralization (https://nnw.fm/jMah9). Silver City was mined from the 11th to late-19th century, until Germany moved off the silver standard in 1873. The deposits in the area were exceptionally high grade, with historical records indicating grades well in excess of 1,000 g/t silver.
Oakley Project – Exploration
The Oakley Project, located in Oakley, Idaho, is an exploration project with land holdings of approximately 7,000 acres. The project hosts gold-silver, epithermal hot spring-type mineralization at two targets: Blue Hill Creek and Cold Creek, and detachment-related gold-silver mineralization at Matrix Creek. The Company has granted Centerra (U.S.) Inc. an option to earn in to a 70% interest by, among other things, spending up to US$7 million in exploration expenditures on the project prior to May 2026.
Management Team
Brendan Cahill is the President & Chief Executive Officer of Excellon Resources Inc. He was previously Vice President Corporate Development of Pelangio Exploration Inc., a junior gold exploration company active in Ghana, West Africa. Mr. Cahill is a board member of the Mining Association of Canada, Group Eleven Resources Ltd., and Kore Mining Inc. He holds a law degree from the University of Western Ontario and an undergraduate degree from the University of Toronto.
Alfred Colas is the Company’s Chief Financial Officer. Most recently, he held the title of CFO of Arch Corp., a Toronto-based private-equity investment firm. Mr. Colas has over 18 years of experience in the mining industry. He is a sitting board member for a housing corporation affiliated with the University of Toronto and is a Chartered Professional Accountant. Mr. Colas completed a Bachelor of Commerce at the University of Toronto.
Paul Keller is Excellon’s Chief Operating Officer. He has over 30 years of industry experience in mining and mine development operations. He previously served as the Senior VP of Major Projects and COO of Trevali Mining. He has experience in building mines from greenfield through permitting, design and operation. Mr. Keller holds a Bachelor of Engineering – Mining from Laurentian University.
Ben Pullinger is the Senior Vice President Geology & Corporate Development for Excellon. Ben brings over 15 years of experience in advancing projects from early stage exploration through to production. Most recently, he was Vice President Exploration at Roxgold Inc., where he made a significant contribution toward growing the 55 Zone at Yaramoko Project into a producing mine. Mr. Pullinger serves on the board of Orford Mining. He is a Professional Geologist (Ontario) and holds an Honors Degree in Geology from the University of Johannesburg.
Excellon Resources Inc. (EXN), closed Tuesday’s trading session at $3.24, off by 2.994%, on 99,150 volume. The average volume for the last 3 months is 66,703 and the stock's 52-week low/high is $2.19499993/$3.90000009.
Recent News
- MiningNewsBreaks - Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) Announces Update on Platosa Project Exploration, Compelling Targets
- Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) Is 'One to Watch'
- MiningNewsBreaks - Excellon Resources Inc. (TSX: EXN) (TSX: EXN.WT) (NYSE: EXN) (FRA: E4X2) Announces Results from Platosa Mine Drilling
Mohawk Group Holdings Inc. (NASDAQ: MWK)
The QualityStocks Daily Newsletter would like to spotlight Mohawk Group Holdings Inc. (MWK).
Shares of Mohawk Group Holdings Inc. (NASDAQ:MWK) traded today at $43.13, eclipsing its 52-week high. So far today approximately 249,000 shares have been exchanged, as compared to an average 30-day volume of 958,000 shares. In the past 52 weeks, Mohawk Group Holdings Inc. share prices are bracketed by a low of $1.42 and a high of $43.13 and is now at $42.07, 2,863% above that low price.
Mohawk Group Holdings Inc. (MWK) is a leading tech-enabled consumer products platform that uses machine learning, natural language processing and data analytics to design, develop, market, and sell products. The company’s proprietary AIMEE(R) platform leverages data and AI to automate the design, development and launch of best-selling consumer products.
Mohawk owns and operates 12 brands and sells consumer products in multiple categories ranging from kitchenware and home appliances to environmental appliances, beauty products and even consumer electronics.
Founded in 2014, Mohawk has offices in the United States, Canada, China and the Philippines. The company is always working to capitalize on the strength of the different cities and time zones in which it operates to ensure continued excellence around the world and achieve its goal of becoming the most consumer-centric product company.
AIMEE(R) Platform
AIMEE(R) (AI Mohawk E-commerce Engine) is Mohawk’s proprietary platform that leverages data and AI to:
- Identify new market opportunities;
- Launch new products;
- Automate marketing variables; and
- Analyze and optimize company-owned and operated consumer product brands.
The platform’s core functionalities include:
- Research: Automated research using live market data that tracks exposure and product trends, allowing for the swift discovery of new market and product opportunities;
- Financials: Places data insights in one place, enabling execution across multiple channels to track new product planning, financial projections, inventory levels, media buying and more;
- Trading: The result of an algorithmic solution that has been optimized for live decisions to scale sales and built to implement automated marketing strategies with learning through experimentation; and
- Logistics: Manages logistics to enable faster delivery of products to consumers.
Mohawk’s Business Model
Mohawk’s unique business model is designed to drastically shorten go-to-market time, decreasing the typical 18- to 24-month process to just 6- to 8-months. Using AIMEE(R), Mohawk leverages real-time data-driven opportunities and trend tracking to replace the idea focus group research and development of the standard model.
Marketing time is also reduced between the two models using the AIMEE(R) Trading Engine for data-driven automated marketing and product lifetime management. Through the AIMEE(R) trading engine, the traditional 3-month marketing for a standard go-to-market model is cut to a fraction of the time.
The AIMEE(R) Fulfillment Engine allows for dynamic inventory allocation, fulfillment selection, cost optimization, a third-party logistics network and a 2-day shipping period across almost all of the United States. The standard business model doesn’t support direct distribution or an FBA (fulfilled by Amazon) structure.
Opportunities for Growth and Profitability
Mohawk’s plan to drive growth and profitability in the market includes:
- The continued optimization of product economics by lowering manufacturing and logistical costs through an increase in purchasing power
- The pursuit of higher-value products with larger target markets
- Opportunistically adding new products and categories through acquisitions
- Expansion into the international and new domestic e-commerce marketplaces
- Monetization of its proprietary AIMEE(R) platform by providing access to third-party brands
Mohawk’s long-term goal is to increase its profit margin from 14% in 2020 to 18-20%, using higher average selling prices and lower fulfillment costs as primary drivers. Due to its technology and platform effect, Mohawk’s corporate overhead is expected to increase at a slower pace than sales. Its fixed operating costs long-term target goal is 5%, which follows the current trend (2019 – 19%, 2020 – 13%). It aims for an adjusted EBITDA of 13-15%.
Management Team
Yaniv Sarig has been Mohawk’s President and Chief Executive Officer since September 2018. He is also a co-founder of Mohawk Group Inc. Mr. Sarig has served as the President and Chief Executive Officer of Mohawk Group Inc. since June 2014. Before his role at Mohawk, he led the Financial Services Engineering department at Coverity, a software startup providing code and security solutions to top financial institutions and hedge funds in New York to include the New York Stock Exchange, Nasdaq, JPMorgan Chase and Barclays. Before his Coverity role, Mr. Sarig held lead technical roles at Bloomberg and EPIQ Systems Inc. (NASDAQ: EPIQ). He holds a Bachelor of Science from Touro College. He is fluent in English, French, Hebrew and C++.
Fabrice Hamaide has been the Chief Financial Officer of Mohawk since September 2018. He has also retained the position of Chief Financial Officer for Mohawk Group Inc. since July 2017. Before Mohawk, Mr. Hamaide held numerous financial, CFO and presidential roles in various technological and consumer product companies across Europe and the United States, including Piksel Inc., Atari, Parrot and Logitech. Mr. Hamaide holds an impressive set of credentials, including an MBA from Columbia Business School, an MS in Information Systems Design from Sorbonne University, and a BS in Applied Mathematics from Jussieu University.
Mihal Chaouat-Fix has been the Chief Product Officer for Mohawk since September 2018. Prior to taking this role within the company, she was the Chief Operating Officer, handling the day-to-day leadership and operational management of Mohawk. Before joining Mohawk, Ms. Chaouat-Fix worked in various roles at Gottex Models Ltd. At this international fashion swimwear firm, her focus on marketing, operations and manufacturing saw supply chain and distribution of 12 million units per year to over 40 countries worldwide.
Tomer Pascal has been the Chief Revenue Officer for Mohawk since 2018. He has also served as the Chief Revenue Officer for Mohawk Group Inc. since 2017. Before he joined the Mohawk team, he was the Chief Executive Officer and co-founder of OMG Studios. Throughout his career, Mr. Pascal has held many different co-founder and general management roles, focusing on companies’ marketing and revenue growth in the media and technology industries.
Roi Zahut has held the role of Chief Technology Officer for Mohawk since 2019. Before Mohawk, he served in numerous roles, including CTO of the Advanced Analytics global consulting team at IBM and architect of IBM Metropulse. While in Israel, Mr. Zahut held several senior technical, business and data science roles in startups and consulting to include IBM Israel, Brainbow Ltd. and Matrix IT Ltd. He holds an MSc in Neuroscience with distinction from Bar Ilan University.
Mohawk Group Holdings Inc. (MWK), closed Tuesday’s trading session at $42.00, up 3.9347%, on 961,431 volume. The average volume for the last 3 months is 678,603 and the stock's 52-week low/high is $1.41999995/$43.2700004.
Recent News
- Shares of Mohawk Group Holdings Inc. (MWK) Have Risen Above Previous 52-Week High
- InvestorNewsBreaks - Mohawk Group Holdings Inc. (NASDAQ: MWK) Enters Essential Oils Category Through Strategic Acquisition
- Mohawk Group Holdings Inc.: The Winning Streak Continues (MWK)
Siyata Mobile Inc. (NASDAQ: SYTA) (TSXV: SIM)
The QualityStocks Daily Newsletter would like to spotlight Siyata Mobile Inc. (SYTA).
Siyata Mobile (NASDAQ: SYTA, SYTAW) (TSX.V: SIM), a leading global developer and provider of Push-to-Talk Over Cellular (“PTT/PoC”) systems for enterprise customers, has appointed Peter Goldstein, currently a Siyata Board member, as chairman of its Board of Directors; the company also named Luisa Ingargiola as a new board members; the appointment will be effective as of Feb. 23, 2021. Ingargiola has extensive experience on public company boards and in the capital markets. To view the full press release, visit https://ibn.fm/pgMEQ
Siyata Mobile Inc. (NASDAQ: SYTA) (TSXV: SIM) is a leading global developer and provider of Push-to-Talk Over Cellular (“PTT/PoC”) systems for enterprise customers. The company specializes in connected vehicle products for professional fleets and markets its products under the Uniden® Cellular brand.
Since its inception in 2012, Siyata has amassed a customer base that includes cellular operators, commercial vehicle technology distributors, and fleets of all sizes in Canada, the U.S., Europe, Australia and the Middle East.
Recognized by the Toronto Venture Stock Exchange in 2018 as a Venture Top 50 Company, Siyata aims to deliver the highest quality and most technologically advanced mobile communication devices for global corporate workforces, fleets, homes and buildings.
The company has long been an industry pioneer, delivering the world’s first 3G connected vehicle device as well as the world’s first 4G/LTE vehicle-mounted smartphone for First Responders and commercial fleets and vehicles, thereby creating a new category in the cellular device market with a dedicated smartphone tailor-made for the commercial vehicle market.
Siyata is headquartered in Montréal, Québec, Canada.
Product Portfolio
Siyata’s suite of technology includes numerous PTT and legacy devices, as well as cellular boosters designed to improve cellular signals in corporate warehouses, government embassies, retirement home campuses, banks and manufacturing plants.
The company’s flagship product, the Uniden UV350, is the world’s first vehicle-mounted 4G/LTE smartphone with crystal clear quality, carrier grade PTT, voice, text, video and data applications built into a single device. Specifically designed for First Responder and commercial fleet vehicles, the UV350 runs on cellular LTE networks that provide nationwide and global coverage, replacing traditional single purpose two-way radios that require a monthly fee and limited network coverage.
The Uniden UV350 is currently available through Bell Mobility, Canada’s largest LTE network and PTT community, as well as AT&T in the U.S. Further expanding its availability, Siyata is completing network approval with another U.S. Tier 1 operator to launch the UV350 in Q3 2019.
Management Team
CEO and Chairman Marc Seelenfreund is the founder of Siyata. He is also the founder of Siyata’s parent company, Accel Telecom, an Israel-based company that specializes in importing and distributing innovative cellular and IP devices to fixed line operators and mobile providers within Israel. Prior to establishing Accel, Seelenfreund was a vice president at Sunrise Corporation in New York where he focused on financing publicly traded technology companies. Seelenfreund has a law degree from Bar Ilan University, is a board member at Israel’s leading private university, and has served as an officer in the Israel Defense Forces.
Glenn Kennedy, vice president of sales, has over 25 years of sales experience in the telecommunications industry. Prior to joining Siyata in 2016, Kennedy managed sales nationally for Motorola Canada, HTC Communications Canada, and Sonim Technologies. He holds a bachelor’s degree in honors business administration from the Richard Ivey School of Business at the University of Western Ontario.
CFO Gerald Bernstein, a professional chartered accountant, has spent 20 years focusing on private equity financing and tax efficient corporate structuring in multi-jurisdictional arenas. He holds a bachelor’s degree of commerce as well as a graduate diploma in public accountancy from McGill University. Bernstein has been a member of the Canadian Institute of Chartered Accountants since 1987.
Gidi Bracha, vice president of technology, has served in this position since 2011 and spearheaded the development of both the Truckfone, Voyager and UV350. Bracha served in various key positions at Cellcom, Israel’s leading cellular provider, including head of car mobility products and director of type approvals. Bracha served as an engineer technician in the Anti-Aircraft division of the Air Force in the Israel Defense Forces and holds a bachelor’s degree in engineering and business management from the University of Derby.
Siyata Mobile Inc. (SYTA), closed Tuesday’s trading session at $12.88, up 17.0909%, on 238,162 volume. The average volume for the last 3 months is 50,574 and the stock's 52-week low/high is $3.90000009/$15.1999998.
Recent News
- InvestorNewsBreaks - Siyata Mobile Inc. (NASDAQ: SYTA) (TSX.V: SIM) Announces New Chairman, Member to Board of Directors
- InvestorNewsBreaks - Siyata Mobile Inc. (NASDAQ: SYTA) Secures $550k Purchase Order to Supply First Responders with UV350 In-Vehicle IoT Device
- InvestorNewsBreaks - Siyata Mobile Inc. (NASDAQ: SYTA) Secures US$12.9M in Private Placement
The QualityStocks Numbers Report
The QualityStocks Sponsored News
- 180 Life Sciences Corp. (NASDAQ: ATNF) to Present at the Biotech Showcase(TM) Digital 2021 Conference
- AzurRx BioPharma Inc. (NASDAQ: AZRX) Announces Participation in BIO CEO & Investor Digital Conference
- Amesite (NASDAQ: AMST) Online Learning Platforms Such as Amesite Nerdy Seeing Growth
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) 5 Hot Penny Stocks To Watch As Chinese Tech Shares Lift On Friday
- Brain Scientific Inc. (BRSF) Helps Identify Decision Triggers in Super Bowl Ads and COVID-19 Ads
- Bullfrog Gold Corp. (CSE: BFG) (OTCQB: BFGC) (FSE: 11B) Marketing VP Authors Article on Increasing Need for Disposable Technologies
- Cannabis Strategic Ventures, Inc. (NUGS) Releases Quarterly Financials, Reports More Than 90% Increase in Sales
- CannAssist International Corporation (CNSC) 420 with CNW - CBD May Be the Remedy for Gonorrhea and Other Bacterial Diseases
- Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) to Release Q3 Financial Results, Host Conference Call on February 10
- Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Announces Board Changes
- Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF) Announces Increase in PowerTap Investment, Details of Hydrogen Station Distribution Agreement
- CNS Pharmaceuticals Inc. (NASDAQ: CNSP) New Discovery May Revolutionize the Treatment of Diabetes
- Creatd Inc. (NASDAQ: CRTD) Provides Update on Plant Camp, Win-Win Partnerships
- CloudCommerce (OTCQB: CLWD) Signs New Client - Desert Mountain - to Help Drive Club Membership, Home Sales
- Cybin Inc. (NEO: CYBN) (OTC: CLXPF) Experts Predict What 2021 Psychedelics Space Might Look Like
- DarioHealth Corp. (NASDAQ: DRIO) New Study Discovers Patient's Immune System Continues Building Resistance After Recovering from COVID-19
- Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) New Laser Scanners Could Hasten Decision-Making Processes on Mining Sites
- Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) Is 'One to Watch'
- Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF) Names Audi Retired VP Terence Johnsson to Board
- ev Transportation Services Inc. - to Present at Upcoming Needham Virtual Growth Conference
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Eye-Net to Conduct Technological Demonstrations in Collaboration with Leading European Cellular Provider
- Friendable Inc. (FDBL) Fan Pass 'Pro Services' to Assist Artists Build Their Brand Image
- Gage Cannabis Co. - Poised Amid Michigan’s 1st Anniversary of Recreational Marijuana Sales
- Genprex, Inc. (NASDAQ: GNPX) Announces Formation of Clinical Advisory Board
- Grapefruit USA Inc.'s (GPFT) Releases Preliminary Revenue Numbers, Notes 714% Growth for Calendar Year
- GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) Announces Equity Incentive Plan
- Green Hygienics Holdings Inc. (OTCQB: GRYN) Partners with Massive Media, GG Marketing LLC as Part of Strategic 2021 Sales and Marketing Plan
- Grey Cloak Tech Inc. (GRCK) Announces Exceptional Results from Its Pilot Migraine Study
- HempFusion Wellness Inc. (TSX: CBD.U) (OTC: CBDHF) (FWB:8OO) Hopes as TSX Launch Completed
- Hemptown Organics Corp. - QualityStocksNewsBreaks – Hemptown Organics Featured in ‘America’s Next Investment’
- Hollywall Entertainment Inc. (HWAL) Begins Roll-out of New HW Vision Media and Telecommunications Brand
- HYB Holding Corp. (HYBG) Is 'One to Watch'
- iClick Interactive Asia Group Ltd. (NASDAQ: ICLK) Announces Collaboration with KLWTT to Offer Powerful Oracle CX Suite
- Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Proprietary System Could Help Reduce Bladder Cancer Recurrence
- Innovative Payment Solutions Inc. (OTCQB: IPSI) Announces a Capital Raise of $600K on Company Friendly Terms
- InsuraGuest Technologies Inc. (TSXV: ISGI) (OTCQB: ISGIF) Renews Annual Contract with Wintergreen Resort
- Josemaria Resources Inc. (TSX: JOSE) (OTC: JOSMF) New Coronavirus Outbreak in China Dampens Copper Prices
- Kaival Brands Innovations Group Inc. (KAVL) Enters Strategic Agreement with Potential to Triple Its Distribution Points
- Knightscope, Inc. - KSOC Introduces Innovation to Security Industry
- LexaGene Holdings Inc. (TSX.V: LXG) (OTCQB: LXXGF) Initiates Program to Identify UK, South African COVID Sequences
- Loop Insights Inc. (TSXV: MTRX) (OTCQB: RACMF) Announces Contract to Provide COVID-19 Safety Protocols to Leading Canadian Ski Resort
- Mobius Interactive Ltd. - Sees Growth in U.S. Sports Betting Industry
- MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Announces Trio of Upcoming Investment, Industry Events
- Net Element, Inc. (NASDAQ: NETE) AI Could Help Find EV Charging Infrastructure Gaps by Reading User Reviews
- Pac Roots Cannabis Corp. (CSE: PACR) Builds on Success, Launches into 2021 with Exciting Projects
- PlantX Life Inc. (CSE: VEGA) (FRA: WNT1) (OTCQB: PLTXF) to Collaborate with LA Retail Hot Spot
- Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Announces CannRX Biosciences Partnership
- PowerBand Solutions Inc. (FRA: 1ZVA) (TSXV: PBX) (OTCQB: PWWBF) Plans Private Placement Financing with $5.3M Potential
- Predictive Oncology Inc. (NASDAQ: POAI) Stands to Benefit from Explosive Growth of Precision Medicine
- Pressure BioSciences Inc. (PBIO) to Acquire Assets of International Agrochemical Developer and Supplier
- Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Present at H.C. Wainwright BIOCONNECT 2021
- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Connecticut, Florida Legislators File Psychedelic Mushroom Bills
- Rritual Superfoods Inc. - Eyes Growing Opportunity in Nascent Functional Mushrooms Market
- RYAH Group Inc. - Well Positioned as Data Continues to Shape Future of Medical Research
- Sanwire Corp. (SNWR) Intercept Music Launches 25 Online Retail Stores for Intercept PLUS Artists
- Sharing Services Global Corporation (SHRG) Encourages Individuals to Create Blue Ocean of Opportunity
- Sigma Labs, Inc. (NASDAQ: SGLB) CEO Releases letter to Shareholders
- SinglePoint, Inc. (SING) President Discusses Solar Growth, Hemp Cigarette Sales on MoneyTV with Donald Baillargeon
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) (FRA: WK3D) to Equip First Responders through $1.4M Purchase Order
- Spectrum Global Solutions, Inc. (SGSI) Announces Definitive Agreement to Merge with High Wire Networks
- SRAX Inc. (NASDAQ: SRAX) Sequire Provides Public Companies with Actionable Insights on Investor Activity While Severe Volatility Grips Markets
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) Named Among Top Performing Companies on the OTCQX
- Sugarmade, Inc. (SGMD) Set to Drive 'Strong Margins Up and Down the Chain'
- Sustainable Green Team, Ltd. (SGTM) Vertically Integrated Operations Founded Around Sustainability
- TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) Is 'One to Watch'
- The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) 420 with CNW - Schumer Says Cannabis Legalization Will Be Senate Priority
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) Will Transition Medical Business to Wholesale Model, Offer Products Through Online Platform
- The Movie Studio Inc. (OTC: MVES) Announces Launch of Streaming Platform, Google Play Store App
- Trxade Group Inc. (NASDAQ: MEDS) to Postpone February Virtual Road Show
- United Medical Equipment Business Solutions Network Inc. - Offers Rapid COVID-19 Test Designed to Identify Infection
- VistaGen Therapeutics Inc. (NASDAQ: VTGN) Rise Above Previous 52-Week High
- Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF) Exercises Right to Accelerate Expiry Date of Outstanding 2020 Warrants
- Wrap Technologies Inc. (NASDAQ: WRAP) Announces Strategic Appointments of Chiefs Kathleen O'Toole and Sylvia Moir
- XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) 2021 Strategic Plan Showcases API Potential of XPhyto Therapeutics
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- 180 Life Sciences Corp. (NASDAQ: ATNF) to Present at the Biotech Showcase(TM) Digital 2021 Conference
- AzurRx BioPharma Inc. (NASDAQ: AZRX) Announces Participation in BIO CEO & Investor Digital Conference
- Amesite (NASDAQ: AMST) Online Learning Platforms Such as Amesite Nerdy Seeing Growth
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) 5 Hot Penny Stocks To Watch As Chinese Tech Shares Lift On Friday
- Brain Scientific Inc. (BRSF) Helps Identify Decision Triggers in Super Bowl Ads and COVID-19 Ads
- Bullfrog Gold Corp. (CSE: BFG) (OTCQB: BFGC) (FSE: 11B) Marketing VP Authors Article on Increasing Need for Disposable Technologies
- Cannabis Strategic Ventures, Inc. (NUGS) Releases Quarterly Financials, Reports More Than 90% Increase in Sales
- CannAssist International Corporation (CNSC) Pioneers Promising CiBiDinol Technology
- Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) to Release Q3 Financial Results, Host Conference Call on February 10
- Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Announces Board Changes
- Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF) Announces Increase in PowerTap Investment, Details of Hydrogen Station Distribution Agreement
- CNS Pharmaceuticals Inc. (NASDAQ: CNSP) New Discovery May Revolutionize the Treatment of Diabetes
- Creatd Inc. (NASDAQ: CRTD) Provides Update on Plant Camp, Win-Win Partnerships
- CloudCommerce (OTCQB: CLWD) Signs New Client - Desert Mountain - to Help Drive Club Membership, Home Sales
- Cybin Inc. (NEO: CYBN) (OTC: CLXPF) Experts Predict What 2021 Psychedelics Space Might Look Like
- DarioHealth Corp. (NASDAQ: DRIO) New Study Discovers Patient's Immune System Continues Building Resistance After Recovering from COVID-19
- Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) New Laser Scanners Could Hasten Decision-Making Processes on Mining Sites
- Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) Is 'One to Watch'
- Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF) Names Audi Retired VP Terence Johnsson to Board
- ev Transportation Services Inc. - to Present at Upcoming Needham Virtual Growth Conference
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Partners with Wunder Mobility to Provide Out-of-the-Box Eye-Net Solution
- Friendable Inc. (FDBL) Fan Pass 'Pro Services' to Assist Artists Build Their Brand Image
- Gage Cannabis Co. - Poised Amid Michigan’s 1st Anniversary of Recreational Marijuana Sales
- Genprex, Inc. (NASDAQ: GNPX) Joins Millions to Recognize World Cancer Day
- Grapefruit USA Inc.'s (GPFT) Releases Preliminary Revenue Numbers, Notes 714% Growth for Calendar Year
- GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) Announces Equity Incentive Plan
- Green Hygienics Holdings Inc. (OTCQB: GRYN) Partners with Massive Media, GG Marketing LLC as Part of Strategic 2021 Sales and Marketing Plan
- Grey Cloak Tech Inc. (GRCK) Announces Exceptional Results from Its Pilot Migraine Study
- HempFusion Wellness Inc. (TSX: CBD.U) (OTC: CBDHF) (FWB:8OO) Hopes as TSX Launch Completed
- Hemptown Organics Corp. - QualityStocksNewsBreaks – Hemptown Organics Featured in ‘America’s Next Investment’
- Hollywall Entertainment Inc. (HWAL) Begins Roll-out of New HW Vision Media and Telecommunications Brand
- HYB Holding Corp. (HYBG) Is 'One to Watch'
- iClick Interactive Asia Group Ltd. (NASDAQ: ICLK) Shares of iClick Interactive Asia Group Rise to a New 52-Week High
- Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Proprietary System Could Help Reduce Bladder Cancer Recurrence
- Innovative Payment Solutions Inc. (OTCQB: IPSI) Announces a Capital Raise of $600K on Company Friendly Terms
- InsuraGuest Technologies Inc. (TSXV: ISGI) (OTCQB: ISGIF) Renews Annual Contract with Wintergreen Resort
- Josemaria Resources Inc. (TSX: JOSE) (OTC: JOSMF) New Coronavirus Outbreak in China Dampens Copper Prices
- Kaival Brands Innovations Group Inc. (KAVL) Enters Strategic Agreement with Potential to Triple Its Distribution Points
- Knightscope, Inc. - Reaches 19K Investor Mark
- LexaGene Holdings Inc. (TSX.V: LXG) (OTCQB: LXXGF) Initiates Program to Identify UK, South African COVID Sequences
- Loop Insights Inc. (TSXV: MTRX) (OTCQB: RACMF) Announces Contract to Provide COVID-19 Safety Protocols to Leading Canadian Ski Resort
- Mobius Interactive Ltd. - Sees Growth in U.S. Sports Betting Industry
- MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Announces Trio of Upcoming Investment, Industry Events
- Net Element, Inc. (NASDAQ: NETE) AI Could Help Find EV Charging Infrastructure Gaps by Reading User Reviews
- Pac Roots Cannabis Corp. (CSE: PACR) Builds on Success, Launches into 2021 with Exciting Projects
- PlantX Life Inc. (CSE: VEGA) (FRA: WNT1) (OTCQB: PLTXF) to Collaborate with LA Retail Hot Spot
- Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Announces CannRX Biosciences Partnership
- PowerBand Solutions Inc. (FRA: 1ZVA) (TSXV: PBX) (OTCQB: PWWBF) Plans Private Placement Financing with $5.3M Potential
- Predictive Oncology Inc. (NASDAQ: POAI) Stands to Benefit from Explosive Growth of Precision Medicine
- Pressure BioSciences Inc. (PBIO) to Acquire Assets of International Agrochemical Developer and Supplier
- Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Present at H.C. Wainwright BIOCONNECT 2021
- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) New Hawaii Senate Bill May See Psilocybin Mushroom Therapy Legalized
- Rritual Superfoods Inc. - Eyes Growing Opportunity in Nascent Functional Mushrooms Market
- RYAH Group Inc. - Partners with THC Lab to Launch Dose-Measuring Inhaler and Data Analytics Platform in Italy, Netherlands
- Sanwire Corp. (SNWR) Intercept Music Launches 25 Online Retail Stores for Intercept PLUS Artists
- Sharing Services Global Corporation (SHRG) Encourages Individuals to Create Blue Ocean of Opportunity
- Sigma Labs, Inc. (NASDAQ: SGLB) CEO Releases letter to Shareholders
- SinglePoint, Inc. (SING) President Discusses Solar Growth, Hemp Cigarette Sales on MoneyTV with Donald Baillargeon
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) (FRA: WK3D) to Equip First Responders through $1.4M Purchase Order
- Spectrum Global Solutions, Inc. (SGSI) Announces Definitive Agreement to Merge with High Wire Networks
- SRAX Inc. (NASDAQ: SRAX) Sequire Provides Public Companies with Actionable Insights on Investor Activity While Severe Volatility Grips Markets
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) Named Among Top Performing Companies on the OTCQX
- Sugarmade, Inc. (SGMD) Set to Drive 'Strong Margins Up and Down the Chain'
- Sustainable Green Team, Ltd. (SGTM) Vertically Integrated Operations Founded Around Sustainability
- TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) Is 'One to Watch'
- The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) 420 with CNW - Schumer Says Cannabis Legalization Will Be Senate Priority
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) Will Transition Medical Business to Wholesale Model, Offer Products Through Online Platform
- The Movie Studio Inc. (OTC: MVES) Announces Launch of Streaming Platform, Google Play Store App
- Trxade Group Inc. (NASDAQ: MEDS) to Postpone February Virtual Road Show
- United Medical Equipment Business Solutions Network Inc. - Delivers Essential Solutions During Ongoing Pandemic
- VistaGen Therapeutics Inc. (NASDAQ: VTGN) Rise Above Previous 52-Week High
- Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF) Exercises Right to Accelerate Expiry Date of Outstanding 2020 Warrants
- Wrap Technologies Inc. (NASDAQ: WRAP) Announces Strategic Appointments of Chiefs Kathleen O'Toole and Sylvia Moir
- XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) 2021 Strategic Plan Showcases API Potential of XPhyto Therapeutics
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- 180 Life Sciences Corp. (NASDAQ: ATNF) to Present at the Biotech Showcase(TM) Digital 2021 Conference
- AzurRx BioPharma Inc. (NASDAQ: AZRX) Announces Participation in BIO CEO & Investor Digital Conference
- Amesite (NASDAQ: AMST) Online Learning Platforms Such as Amesite Nerdy Seeing Growth
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) 5 Hot Penny Stocks To Watch As Chinese Tech Shares Lift On Friday
- Brain Scientific Inc. (BRSF) Helps Identify Decision Triggers in Super Bowl Ads and COVID-19 Ads
- Bullfrog Gold Corp. (CSE: BFG) (OTCQB: BFGC) (FSE: 11B) Marketing VP Authors Article on Increasing Need for Disposable Technologies
- Cannabis Strategic Ventures, Inc. (NUGS) Releases Quarterly Financials, Reports More Than 90% Increase in Sales
- CannAssist International Corporation (CNSC) Pioneers Promising CiBiDinol Technology
- Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) to Release Q3 Financial Results, Host Conference Call on February 10
- Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Announces Board Changes
- Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF) Announces Increase in PowerTap Investment, Details of Hydrogen Station Distribution Agreement
- CNS Pharmaceuticals Inc. (NASDAQ: CNSP) New Discovery May Revolutionize the Treatment of Diabetes
- Creatd Inc. (NASDAQ: CRTD) Provides Update on Plant Camp, Win-Win Partnerships
- CloudCommerce (OTCQB: CLWD) Signs New Client - Desert Mountain - to Help Drive Club Membership, Home Sales
- Cybin Inc. (NEO: CYBN) (OTC: CLXPF) Experts Predict What 2021 Psychedelics Space Might Look Like
- DarioHealth Corp. (NASDAQ: DRIO) New Study Discovers Patient's Immune System Continues Building Resistance After Recovering from COVID-19
- Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) New Laser Scanners Could Hasten Decision-Making Processes on Mining Sites
- Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) Is 'One to Watch'
- Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF) Names Audi Retired VP Terence Johnsson to Board
- ev Transportation Services Inc. - to Present at Upcoming Needham Virtual Growth Conference
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Partners with Wunder Mobility to Provide Out-of-the-Box Eye-Net Solution
- Friendable Inc. (FDBL) Fan Pass 'Pro Services' to Assist Artists Build Their Brand Image
- Gage Cannabis Co. - Poised Amid Michigan’s 1st Anniversary of Recreational Marijuana Sales
- Genprex, Inc. (NASDAQ: GNPX) Joins Millions to Recognize World Cancer Day
- Grapefruit USA Inc.'s (GPFT) Releases Preliminary Revenue Numbers, Notes 714% Growth for Calendar Year
- GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) Announces Equity Incentive Plan
- Green Hygienics Holdings Inc. (OTCQB: GRYN) Partners with Massive Media, GG Marketing LLC as Part of Strategic 2021 Sales and Marketing Plan
- Grey Cloak Tech Inc. (GRCK) Announces Exceptional Results from Its Pilot Migraine Study
- HempFusion Wellness Inc. (TSX: CBD.U) (OTC: CBDHF) (FWB:8OO) Hopes as TSX Launch Completed
- Hemptown Organics Corp. - QualityStocksNewsBreaks – Hemptown Organics Featured in ‘America’s Next Investment’
- Hollywall Entertainment Inc. (HWAL) Begins Roll-out of New HW Vision Media and Telecommunications Brand
- HYB Holding Corp. (HYBG) Is 'One to Watch'
- iClick Interactive Asia Group Ltd. (NASDAQ: ICLK) Shares of iClick Interactive Asia Group Rise to a New 52-Week High
- Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Proprietary System Could Help Reduce Bladder Cancer Recurrence
- Innovative Payment Solutions Inc. (OTCQB: IPSI) Announces a Capital Raise of $600K on Company Friendly Terms
- InsuraGuest Technologies Inc. (TSXV: ISGI) (OTCQB: ISGIF) Renews Annual Contract with Wintergreen Resort
- Josemaria Resources Inc. (TSX: JOSE) (OTC: JOSMF) New Coronavirus Outbreak in China Dampens Copper Prices
- Kaival Brands Innovations Group Inc. (KAVL) Enters Strategic Agreement with Potential to Triple Its Distribution Points
- Knightscope, Inc. - Reaches 19K Investor Mark
- LexaGene Holdings Inc. (TSX.V: LXG) (OTCQB: LXXGF) Initiates Program to Identify UK, South African COVID Sequences
- Loop Insights Inc. (TSXV: MTRX) (OTCQB: RACMF) Announces Contract to Provide COVID-19 Safety Protocols to Leading Canadian Ski Resort
- Mobius Interactive Ltd. - Sees Growth in U.S. Sports Betting Industry
- MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Announces Trio of Upcoming Investment, Industry Events
- Net Element, Inc. (NASDAQ: NETE) AI Could Help Find EV Charging Infrastructure Gaps by Reading User Reviews
- Pac Roots Cannabis Corp. (CSE: PACR) Builds on Success, Launches into 2021 with Exciting Projects
- PlantX Life Inc. (CSE: VEGA) (FRA: WNT1) (OTCQB: PLTXF) to Collaborate with LA Retail Hot Spot
- Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Announces CannRX Biosciences Partnership
- PowerBand Solutions Inc. (FRA: 1ZVA) (TSXV: PBX) (OTCQB: PWWBF) Plans Private Placement Financing with $5.3M Potential
- Predictive Oncology Inc. (NASDAQ: POAI) Stands to Benefit from Explosive Growth of Precision Medicine
- Pressure BioSciences Inc. (PBIO) to Acquire Assets of International Agrochemical Developer and Supplier
- Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Present at H.C. Wainwright BIOCONNECT 2021
- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) New Hawaii Senate Bill May See Psilocybin Mushroom Therapy Legalized
- Rritual Superfoods Inc. - Eyes Growing Opportunity in Nascent Functional Mushrooms Market
- RYAH Group Inc. - Partners with THC Lab to Launch Dose-Measuring Inhaler and Data Analytics Platform in Italy, Netherlands
- Sanwire Corp. (SNWR) Intercept Music Launches 25 Online Retail Stores for Intercept PLUS Artists
- Sharing Services Global Corporation (SHRG) Encourages Individuals to Create Blue Ocean of Opportunity
- Sigma Labs, Inc. (NASDAQ: SGLB) CEO Releases letter to Shareholders
- SinglePoint, Inc. (SING) President Discusses Solar Growth, Hemp Cigarette Sales on MoneyTV with Donald Baillargeon
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) (FRA: WK3D) to Equip First Responders through $1.4M Purchase Order
- Spectrum Global Solutions, Inc. (SGSI) Announces Definitive Agreement to Merge with High Wire Networks
- SRAX Inc. (NASDAQ: SRAX) Sequire Provides Public Companies with Actionable Insights on Investor Activity While Severe Volatility Grips Markets
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) Named Among Top Performing Companies on the OTCQX
- Sugarmade, Inc. (SGMD) Set to Drive 'Strong Margins Up and Down the Chain'
- Sustainable Green Team, Ltd. (SGTM) Vertically Integrated Operations Founded Around Sustainability
- TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) Is 'One to Watch'
- The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) 420 with CNW - Schumer Says Cannabis Legalization Will Be Senate Priority
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) Will Transition Medical Business to Wholesale Model, Offer Products Through Online Platform
- The Movie Studio Inc. (OTC: MVES) Announces Launch of Streaming Platform, Google Play Store App
- Trxade Group Inc. (NASDAQ: MEDS) to Postpone February Virtual Road Show
- United Medical Equipment Business Solutions Network Inc. - Delivers Essential Solutions During Ongoing Pandemic
- VistaGen Therapeutics Inc. (NASDAQ: VTGN) Rise Above Previous 52-Week High
- Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF) Exercises Right to Accelerate Expiry Date of Outstanding 2020 Warrants
- Wrap Technologies Inc. (NASDAQ: WRAP) Announces Strategic Appointments of Chiefs Kathleen O'Toole and Sylvia Moir
- XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) 2021 Strategic Plan Showcases API Potential of XPhyto Therapeutics
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.